A profile of the auditory function of children with TB receiving ototoxic medication at Brooklyn Chest Hospital by Ghafari, Nazanin
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 










A Profile of the Auditory Function of Children with TB Receiving Ototoxic 
Medication at Brooklyn Chest Hospital 
N azanin Ghafari 
GHFNAZOOI 
Submitted in fulfilment of the requirements for the degree MSc. Audiology 
In the Division of Communication Sciences and Disorders 
Faculty of Health Sciences 
University of Cape Town 
February 2012 
Supervisor: Prof Shajila Singh 
Co-supervisors: 
Mrs Christine Rogers 










~"<1M.jP' . • 
Table of Contents 
Declaration 
Acknowledgements 
List of Tables 




Global and Regional Incidence ofTB 
Incidence of TB in Children 
Nature ofTB in Children 
Management of TB in Children 
Nature of Management 
Medical Management 
Side Effects and Impact of TB drugs 
Institutionalization 
Side Effects and Impact 
Prevalence of Auditory Dysfunction in Children with TB 
Auditory Monitoring in Ototoxicity 
Institutionalization of Children at Brooklyn Chest Hospital for TB 
Hearing Evaluation 








































































Prevalence of Outer Ear Abnormalities Pre and Post Medical Intervention 47 
Prevalence of Middle Ear Abnormalities Pre and Post Medical Intervention 47 
Appearance of the Tympanic Membrane 47 
Function of the Middle Ear 48 
Impedance and Admittance 48 
Ipsilateral Acoustic Reflexes 49 
Unresolved Middle Ear Abnormality 50 
Summary of the Prevalence of the Outer and Middle Ear Abnormalities Before 51 
and after Medical Intervention 
Prevalence of Hearing loss 52 
Nature of the Hearing Loss 53 
Type and Configuration of the Hearing Loss 53 
Degree 53 
Laterality and Symmetry 54 
Summary of the Prevalence and Nature of the Hearing loss 54 
Determination of the Relationship between Middle Ear Abnormality and Sex 56 
Determination of the Relationship between Middle Ear Abnormality and Age 56 
Determination of the Relationship between Middle Ear Abnormality and Duration 56 
of Hospitalization 
Determination of the Relationship between Duration of Ototoxic Drug Exposure 57 
and Sensorineural Hearing Loss 
Determination of the Relationship between Type of Ototoxic Drug and 57 
Sensorineural Hearing Loss 
Determination of the Relationship between Type of TB and Sensorineural Hearing 57 
LosslMiddle Ear Abnormality 
Determination of the Relationship between Middle Ear Abnormality and 58 
Comorbid Presentation of HIV and TB 
Determination of the Relationship between Sensorineural Hearing Loss and 58 
Comorbid Presentation ofHIV and TB 
Auditory Function of Participants with TB who are Receiving Ototoxic Drugs 58 
Discussion 59 
Prevalence of Outer and Middle Ear Abnormalities 59 
Prevalence and Nature of the Hearing Loss 62 
Determination of the Relationship between Sensorineural Hearing LosslMiddle 70 




Appendix A: Participant Characteristics 
Appendix B: Proof of Registration with HPCSA 
96 
97 
Appendix C: Ethical Approval from UCT's Faculty of Health Sciences Research 98 
Ethics Committee 










Appendix E: An Outline of the Information Shared with Children who Were Old toO 
Enough to Participate in the Decision Making 
Appendix F: Informed Consent Forms in English 103 
Appendix G: Informed Consent Forms in IsiXhosa 114 
Appendix H: Informed Consent Forms in Afrikaans 126 
Appendix I: Procedure of Getting Ethical Approval and Consent From Parents and 137 
their Children 
Appendix J: Procedure of Audiological Examination 138 











I, Nazanin Ghafari, hereby declare that the work on which this dissertation is based is my 
original work (except where acknowledgements indicate otherwise) and that neither the whole 
work nor any part of it has been, is being, or is to be submitted for another degree in this or any 
other university. 
I empower the university to reproduce for the purpose of research either the whole or any 
portion of the contents in any manner whatsoever. 
,0 ';.1'\" _" 













I would like to acknowledge Prof Shajila Singh, my supervisor, for her tireless dedication, 
expertise and guidance which made this journey possible. For that I am sincerely thankful. I 
would also like to thank Christine Rogers and Lucretia Peterson, my co-supervisors, for their 
encouragement and constructive comments. I would also like to thank Brooklyn Chest hospital 
and its staff specially Dr Marianne Willemse, the paediatrician, and Kayleen Jacobs, senior 
audiologist, for their kind clinical assistance. 
A special dedication to my family, my mom Nasrin, my dad Dariush and my sister 
Nastaran, I love you all. Amir, my dearest husband, without your support and editorial work, I 
























List of Tables 
Illustration of the Tests Protocol and Equipment Used to Assess Auditory 24 
Function in different Age Groups 
The Sensitivity and Specificity of the Tests Used to Assess the Integrity of 31 
the Auditory Pathway 
Determination of the Normality and Abnormality of Middle Ear 
Determination of Hearing Status 
41 
42 
Determination of Configuration of Hearing Loss 43 
Determination of the Degree of Hearing Loss Based on the Northern and 44 
Downs Classification and the Adapted Proposed Classification 
Nature and Frequency of Tympanic Membranes with Abnormal 49 
Appearance (Pre and Post Medical Intervention) 
Conditions which may have Contributed to Participants' Absent Ipsilateral 50 
Acoustic Reflexes 
Frequency and Nature of Middle Ear Abnormality of Ears Referred for 51 
Medical Intervention 
Outer and Middle Ear Status in Three Different Age Groups (pre and post 52 
medical intervention) 
Hearing Status of the Ears 54 
Degree of Hearing Loss Based on the Conventional PTA and High 55 
Frequencies PTA 






















Glossary of Terms 
Auditory Steady-State Response (ASSR) audiometry is a test which can 
accurately predict the behavioural pure-tone audiogram (Aoyagi et al., 
2007) 
Hearing loss of average 15dB at 0.5, 1, 2 kHz or average of 30 dB at 3, 4, 
6 kHz between two ears (American Academy of Otolaryngology-Head 
and Neck Surgery, 1997) 
One of the complications of primary TB that has spread from the lungs to 
other parts of the body through the blood stream or lymphatic system 
(Jeyapaul, 2007). 
"Resistance to at least isoniazid, rifampin, tluoroquinolones, and either 
aminoglycosides or capreomycin" (Young, Chick, Kormos & Goroll, 
201 0, p.145) 
"Resistance to at least isoniazid, rifampin" (Young et al., 2010, p.145) 
Having or made up of few bacilli (The American Heritage Medical 
Dictionary, 2007) 
Pre extensively Disease caused by a strain resistant to isoniazid and rifampin and either a 
drug-resistant tluoroquinolone or a second-line injectable drug, but not both (BaneIjee et 












A descriptive survey research design was used to describe the auditory function of children with 
tuberculosis (TB) receiving ototoxic medication at Brooklyn Chest Hospital. A battery of 
audiologic tests (otoscopy, immittance, audiometry or OAE and AABR) were conducted on 29 
children, aged 0 to 18 years, and the results were analysed using descriptive statistics and 
Generalized Linear Models. The results suggest that 55% of children had middle ear abnormality 
and 48% had hearing loss. The degree of hearing loss ranged from mild to profound in 41 % of 
the cases while 59% had hearing within the normal range with their loss restricted to high 
frequencies. No statistically significant associations were found between sex, duration of 
hospitalization, comorbid presentation of HIV and TB and middle ear abnormality. There was 
also no significant relationship between sensorineural hearing loss and comorbid presentation of 
HIV and TB. The frequency of middle ear abnormality was significantly lower for the age group 
3 to 7 years (X = ~.620, df = 2, p = .038). Conclusion: (i) An ototoxicity monitoring program 
should be routinely implemented with all children receiving· ototoxic TB medication for early 
identification of ototoxic hearing loss, in order, to prevent or minimise further loss and provide 
appropriate audiologic services for this popUlation. (ii) The North~m and Downs's degree of 
hearing loss classification system, based on average thresholds for speech frequencies may not 
be suitable for determining severity of ototoxic hearing loss, which initially occurs at high 
frequencies. It is therefore recommended that for children at risk of ototoxic hearing loss, the 
Northern and Downs's classification should be based on the average degree of thresholds in high 
frequencies (4 & 8 kHz). 












South Africa with 0.46 million TB cases in 2007, ranked fifth among 22 high-burden TB 
countries (WHO, 2009). About 15-20% of the total number of TB cases in many developing 
countries are children under 15 years of age (Marais, Schaaf & Donald, 2009). Children account 
for a significant proportion of TB cases in the Western Cape province, South Africa, where a 
high prevalence of TB has been reported (Marais, Hesseling, Gie, Schaaf & Beyers, 2006). 
Children with TB are often hospitalized and medicated with first-line or second-line drugs 
(WHO, 2006; Espinal et al., 2000), some of which are ototoxic and may lead to severe, bilateral 
and permanent hearing loss (Xing, Chen & Cao, 2007). Hospitalization increases the risk of ear 
infections in children which may also lead to hearing loss (Rizzo, 2002; Garner et al., 1996). 
Undetected hearing loss can have adverse effects on the child's language, psychosocial and educational 
development (Copley & Friderichs, 2010; Northern & Downs, 2002). The effects of ototoxicity in 
adults are well described in the literature and have been discussed since shortly after the-
introduction of the first aminoglycoside, streptomycin, in the 1940s (Bagger-Sjoback, 1997). 
However, there are few studies on children. Such studies are crucial and may help develop an 
appropriate hearing monitoring programme which can be routinely implemented to facilitate 
management and planning for service delivery to this population. The present study aimed to 
describe the auditory function of children hospitalized with TB receiving ototoxic medication at 
Brooklyn Chest Hospital, the main referral centre for TB in the Western Cape. The possible 
relationship between sensorineural hearing loss! middle ear abnormality and parameters such as 













Global and Regional Incidence of Tuberculosis 
Each year tuberculosis infects over nine million individuals around the world with a third from 
African countries (Palitza, 2010). South Africa with 0.46 million TB cases in 2007, ranked fifth 
among 22 high-burden TB countries (WHO, 2009). The rate ofTB in this country was estimated 
to be 960 cases per 100 000 population in 2008 (WHO, 2010). A high incidence of TB was 
found in the Western Cape Province with 967 cases per 100000 population in 2004 (Western 
Cape Department of Health. 2006). In 2004 and 2005. the incidence in Cape Town was 810 and 
874/100000 populations, respectively (Western Cape Department of Health. 2006). 
In 2002, the WHO reported that the prevalence of TB in Africa was increasing after 40 years of 
decline. Poor health services, the emergence of multidrug-resistant TB and the high incidence of 
HN/AIDS have contributed to the disease resurgence (WHO, 2002). In South Africa about 55% 
of TB cases are HN positive (Setswe, 2009) rendering the diagnosis and treatment of this 
disease difficult (Jeena, Pillay, Pillay & Coovadia, 2002; Swaminathan, 2004). Both HN and TB 
are more common in impoverished societies, a result of inferior living conditions, such as poor 
public-health, malnutrition, overcrowding, homelessness and lack of education (Killewo, 2002; 
Figueroa-Munoz & Ramon-Pardo, 2008). It has been estimated that in South Africa poverty 
currently affects 40% of the population (Health Systems Trust, 2008) prone to HN and TB 
infections. Those who succumb to these infections are often unable to work and become 
subsequently poor, so the cycle of poverty, HN and TB continues (Killewo, 2002). Children 
account for a significant proportion of TB cases, especially in impoverished societies with high 











particularly more vulnerable to TB than adults because of their developing immune systems and 
those who are borne HIV positive or live in poverty are even at higher risk of acquiring this 
infection (Killewo, 2002; Palitza, 2010). 
Incidence of TB in children. The WHO data on the incidence of TB in children focuses 
only on smear-positive cases. In 2002, 1.8% of the smear-positive cases in Africa were children 
(Cooreman, 2006). Since smears are rarely positive in children with TB, this report reflects only 
a minor fraction of the total cases, and thus the true incidence of TB in children is unknown 
(Cooreman, 2006). It is estimated that about15-20% of the total TB cases in many developing 
countries including South Africa are children under 15 years of age (Marais et al., 2009). 
Nationally, about nine percent of all TB cases occur in children under four years of age 
(Sigwebela, 2010). There are no detailed statistics available for the number of paediatric TB cases 
in South Africa (Palitza, 2010) but the abovementioned percentages indicate that, an appreciable 
proportion of the population with TB are children. The lack of accurate data on childhood TB 
will negatively influence and limit future research in this area and planning for health service 
delivery to this popUlation. 
Nature of Tuberculosis in Children 
Children are more likely to develop TB after infection by Mycobacterium tuberculosis (5 to 10% 
in adults vs 24 to 43% in children) and are significantly more prone to develop extra pulmonary 
and severe disseminated TB than adults because of their weaker immune systems (Lewinsohn, 
Gennaro, Scholvinck & Lewinsohn, 2004). All forms ofTB are more common in HIV-infected 
children as a result of their severely compromised immune systems (Palitza, 2010). The severity 











HIV infection progresses and immunity declines, TB tends to spread throughout the body to 
involve different organs (WHO, 2003). Diagnostic error and delayed diagnosis of TB are 
common among HIV infected children, since the radiographic manifestations of TB overlap with 
other lung diseases (Jeena, Pillay, Pillay & Coovadia, 2002; Swaminathan, 2004). Misdiagnosis 
may lead to development of drug-resistant TB (Davies, 2001). Treatment of TB, especially 
drug-resistant TB can lead to ototoxicity in children, this will be discussed in full detail under the 
heading "Side effects & impact ofTB drugs" . 
. Management of Tuberculosis in Children 
Nature of management. Children who are suspected to have TB or are diagnosed with 
TB require medical management (Edward & Nardell, 2009). Depending on the nature of the TB 
and the. child's physical status, further management may be required through institutionalization 
(WHO, 2006 a; Edward & Nardell, 2009). 
Medical management. Medical management of TB involves prescription of medication, 
supervision and patient support programs (Department of Health, 2004). First-line and second-
line drugs are used for medical intervention. First line drugs (isoniazid, rifampicin, 
pyrazinamide, ethambutol, and streptomycin) are prescribed for children with drug-susceptible 
TB and may have unpleasant side effects including ototoxicity (Espinal et aI., 2000; Kamal, 
Azeeza, Malik, Shaik & Rao, 2008). Directly observed treatment short-course (DOTS) involves 
utilization of first-line medication (WHO, 2003). The length of treatment with fIrst-line drugs is 
about six to eight months (Jindani, Numm & Enarson, 2004). The second line drugs (amikacin, 
kanamycin, capreomycin, viomycin, ciprofloxacin, moxifloxacin, ofloxacin, ethionamide, 











resistance TB (MDR-TB) and may also have adverse effects including ototoxicity. Treatment 
with second-line drugs takes 18 to 24 months and DOTS-Plus facilitates the taking of these 
medications (WHO, 2003). It is estimated that the success rate of DOTS-Plus in 2010 for 
treatment of patients with MDR-TB (including children) is 73% in African countries, like South 
Africa, with high incidence ofHIV (WHO, 2006 b). The success rate of DOTS for treatment of 
all South Africans with TB increased from 65 percent in 2001 to 74 percent in 2006 (WHO, 
2010). 
Side effects & impact of TB drugs. The two most toxic classes of TB drugs are 
aminoglycosides (streptomycin, kanamycin and amikacin) and polypeptides (capreomycin) with 
ototoxic and nephrotoxic side effects (Kamal et al., 2008). The nephrotoxicity is often reversible 
but the ototoxicity is severe, bilateral and permanent (Xing et aI., 2007; Guthrie, 2008). 
Ototoxicity involves vestibulotoxicity and cochleotoxicity (Rybak, Touliatos & Campbell, 2006). 
Vestibulotoxicity 
Streptomycin is vestibulotoxic (Rybak & Ramkumart, 2007; Peloquin et al., 2004). 
Vestibulotoxicity is the result of damage to the vestibular sensory neuroepithelium with the most 
extensive hair cell damage occuring in the apex of the ampullar cristae and the striolar regions of 
the maculae of the saccule and utricle (Rybak et al., 2006). Vestibulotoxicity can affect 
equilibrium which in turn may lead to oscillopsia and disequilibrium (Rybak et at., 2006). 
Cochleotoxicity 
Amikacin, kanamycin and capreomycin are all cochleotoxic (Hain, 2010) however it has been 
suggested that capreomycin might be less cochleotoxic than the former two drugs (Sturdy et al., 











cochlea (Xing et al., 2007; Guthrie, 2008). Exposure to ototoxic drugs initially affects the base of 
the cochlea, where the hair cells code for high frequencies. With continued exposure, damage to 
the apex of the cochlea ensues (the low frequency coding region) (Xing et al., 2007; Guthrie, 
2008). The duration of exposure to these drugs may be associated with cochleotoxicity. Some 
studies have found no significant associtiation between the duration of ototoxic treatment and 
cochleotoxicity (Sturdy et al., 2011; de Jager and van Altena, 2002; Lima, Lessa, Aguiar-Santos 
& Medeiros, 2006), while others have come to the conclusion that the risk of cochleotoxicity 
increases with prolonged duration of treatment (Arbex, Varella~ Siqueira~ Mello~ 2010; Peloquin 
et al., 2004). Cochleotoxicity may have an impact on hearing and in children can affect the 
acquisition or further development of speech, language, communication and learning. The impact 
of hearing loss in children is discussed later, but it is evident that every effort needs to be made 
to prevent or minimize the effects of cochleotoxic hearing loss in children (Vasquez & Mattucci, 
2003). 
Susceptibility 
In general there are a number of risk factors which predispose TB patients including children to 
drug-induced ototoxicity, such as serum drug levels; previous sensorineural hearing loss; 
genotype; simultaneous administration of other known ototoxic agents (loop diuretics, aspirin); 
concomitant noise exposure; duration of therapy with ototoxic drugs in excess of seven days and 
the very young (neonates), (Monsell et al., 2007; Kokotas, Petersen & Willems, 2007). While 
currently there are no studies to determine possible risk factors for drug induced ototoxicity in 
children with TB, there is some suggestion that children may be at greater risk for ototoxicity 











Institutionalization. Hospitalization of children may be necessary for management of 
TB. The main indications for hospitalization of patients with TB including children are severe 
fonns of the disease, co-infections (e.g. HN), severe TB drug reactions, the need for diagnostic 
procedures and social issues which may lead to non-compliance (e.g. homelessness), (Edward & 
Nardell, 2009). The duration of drug treatment for TB is about 6 months to two years but the 
exact length of hospitalization is not known (Jindani et al., 2004; WHO, 2003). 
Side effects & impact of institutionalization. Ear infection and linguistic deprivation are 
the most important side effects of institutionalization of children with TB (Ruben, 2003; Rizzo, 
2002; Garner, Jarvis, Emori, Horan & Hughes, 1996). Linguistic deprivation and the resultant 
hearing loss from ear infections may negatively influence speech and language development in 
children, which is thoroughly discussed in the following section. 
Ear Infection 
All hospitalized children with TB are susceptible to contracting an ear infection (Rizzo, 2002; 
Garner et al., 1996) but children with compromised immune systems (e. g. those infected with 
HN) and young children are at greater risk than others (Rizzo, 2002). Children in health care 
institutions are in close contact with other potentially sick children, increasing their risk of upper 
respiratory tract infections, which can lead to otitis media (Cober & Johnson, 2005). Ear 
infection or otitis media is common during childhood and affects sound conduction in the middle 
ear (Silveira Netto, da Costa, Sleifer & Braga, 2009). Untreated otitis media may result in 
serious complications (Bluestone & Klein, 2003). The infection can spread from the middle ear 
to nearby structures, including the brain (Racanello & McCabe, 2010). Persistent fluid in the 











moderate conductive hearing loss. When otitis media involves the cochlea, it may cause 
sensorineural hearing loss which varies from mild to profound (Bluestone & Klein, 2003; 
Bluestone & Klein, 2007). Untreated otitis media affects the child's hearing ability and thus may 
lead to speech and language disabilities (Racanello & McCabe, 2010). The impact of hearing 
loss in children will be discussed in detail later. 
Linguistic Dg>rivation 
Children who have been hospitalized for a long time may experience linguistic deprivation 
(Ruben, 2003), which is particularly true in developing countries including South Africa, where 
the institutional conditions are quite poor (Ruben, 2003). Shortage of staff and the increasing 
number of hospitalized children result in inadequate linguistic stimulation (Nelson, 2007). 
Parental absenteeism and neglect by hospital staff may restrict the child's interaction with 
nurses/parents with very little language input, both in quantity and quality (Nelson, 2007; Leung, 
2010). In addition, in multi-lingual countries such as South Africa staff and patients may not 
have a common language. Lack of adequate linguistic stimulation may lead to linguistic 
deprivation which can be deleterious for children's speech and language development (Ruben, 
2003). 
As mentioned, hospitalized children with TB are at increased risk of both linguistic deprivation 
and middle ear infections. Linguistic deprivation combined with the hearing loss induced by 
middle ear infections, can lead to speech and language disorders (Ruben, 2003). Thus, early 












Prevalence of Auditory Dysfunctions in Children with TB 
Following extensive search of the literature, using Google Scholar and Pubmed search engines, 
there were no documented studies which assessed the ototoxicity in children with TB. The only 
issue investigated was the prevalence of ototoxicity in adult TB patients. This review will 
therefore focus on the prevalence of ototoxic hearing loss in adults (since it may have some 
implications for children) and the prevalence of common outer and middle ear abnormalities in 
children. 
In general, outer ear abnormalities do not affect the hearing unless there is blockage of 
the ear canal e.g. impacted wax (Stach, 2008). Impacted wax is the most common ear problem 
among school children (Phaneendra Rao, Subramanyam, Nair & Rajashekhar, 2002; Adhikari, 
2009), which can result in conductive hearing loss (Subha & Raman, 2006). Minja and 
Machemba (1996) and Brkic (2010) reported prevalence rates of 15.7% and 24% for impacted 
wax among school children in Tanzania and Bosnia and Herzegovina respectively, while 
Phaneendra Raoet al. (2002) and Adhikari (2009) reported much higher prevalence rates of 63% 
and 62% among rural school children in India and Nepal respectively. The prevalence rates of 
impacted wax in school children in developing countries indicate a possibly high incidence of 
this preventable condition in South Africans school-aged children including those with TB. 
Middle ear abnormalities may cause conductive and even sensorineural hearing loss 
(Bluestone & Klein, 2007). Otitis media is the most common middle ear abnormality in children, 
which is more prevalent during the cold months of the year (Okur, Yildirim, Akif Kilic, 
Guzelsoy, 2004; Adhikari, 2009). The prevalence of otitis media with effusion is significantly 











vulnerable to this disease and as they grow older its incidence decreases (Caylan, 2005; Zielhuis 
et al., 1990). It is not clear whether sex plays a role in the prevalence of otitis media with 
effusion. Caylan (2005) reported the prevalence of otitis media with effusion to be significantly 
more in male children in Turkey, while Martines (2010) found the prevalence to be significantly 
more in female children in Italy. Tong et al. (2006) in China found no real differences between 
the sexes. 
Most of the studies which assessed the middle ear status of school children, have reported 
on abnormalities of middle ear and tympanic membrane separately. In this review, in order to 
report on the prevalence of middle ear abnormality in these studies, the number of the tympanic 
membranes and middle ear abnormalities were added together (when the same child did not 
present with more than one abnormality). Adhikari (2009), Olusanya, Okolo and Ijaduola (2000), 
and Sockalingham, Hives and Kel (2003) reported the prevalence rates of middle ear abnormality 
(combined prevalence rate of middle ear and tympanic membrane abnormalities) to be 15%,49% 
and 53% among school children in Nepal, Nigeria and Australia (among Aboriginal school-aged 
children) respectively. These high prevalence rates of middle ear abnormality in school children 
together with the vulnerability of hospitalized and younger children to ear infections indicate the 
need to assess the middle ear status of hospitalized children with TB for the presence of any 
abnormality. 
As mentioned earlier, no study has ever been conducted to determine the prevalence of 
ototoxic hearing loss in children with TB, while there are numerous reports on the prevalence of 
ototoxic hearing loss in adults. Thus, it is difficult to estimate the percentage of children with 
TB who may be at risk of ototoxic hearing loss in South Africa. However, it would be wise to 











drugs as the South African children (amikacin, kanamycin, streptomycin or capreomycin), since 
this may shed some light on the prevalence of ototoxic hearing loss among children with TB in 
South Africa. The prevalence of ototoxic hearing loss in developed countries such as the 
Netherlands, UK and USA has been reported to be 18%,28% and 37% respectively (De Jager & 
van Altena, 2002; Peloquin et al., 2004; Sturdy et al., 2011) while the prevalence rates in 
developing countries such as India, Turkey and Brazil were 18.7%, 42% and 64% (Duggal 
&Sarkar, 2007; Tourn et al., 2005; Lima et ai., 2006). 
The reported high prevalence rates of ototoxic hearing loss in adults and the fact that 
children may be more vulnerable to ototoxicity than similarly treated adults (Schell et ai., 1989; 
Kokotas et ai., 2007) strongly suggest a possible high prevalence of ototoxic hearing loss in 
children with TB receiving ototoxic drugs. Ototoxicity is an important health issue, which 
requires active monitoring and periodic assessment of the hearing status of children receiving 
ototoxic TB drugs. 
Auditory Monitoring in Ototoxicity 
The goal of an ototoxicity monitoring programme is to detect early changes in hearing thresholds 
to preserve hearing before there is damage in the speech frequency range (Jacob, Aguiar, 
Tomiasj, Tschoeke & Bitencourt, 2006; Kathleen, 2004; Campbell, 2004). The moment early 
changes of hearing thresholds are detected, the dosage of the offending agent must be limited and 
an alternative drug should be considered (WHO, 2003; Jacob et al., 2006). 
ASHA (1994) presented guidelines for monitoring the hearing of all individuals receiving 
cochleotoxic medication. According to these guidelines, a baseline hearing evaluation should be 











evaluations also need to be performed at 3 months, 6 months,and 1 year post-treatment intervals 
to detect ototoxic hearing loss. The baseline evaluation must be a complete audiologic 
assessment including speech audiometry and acoustic immittance measure (ASHA , 1994). The 
basic monitoring evaluations, which should be performed weekly throughout the treatment, 
include otoscopic examination and air-conduction threshold (ASHA, 1994). High frequency 
audiometry (9 to 20 kHz) is also recommended to provide maximum hearing sensitivity 
information (Goodman, Fitzpatrick, Ellison, Jesteadt & Keefe, 2009; 2006; ASHA, 1994). 
Moreover, objective measures, such as evoked otoacoustic emissions and brainstem evoked 
response audiometry should be carried out when the patient is unable to respond to SUbjective 
testing e.g. young children (Stavroulaki et al., 2002; ASHA, 1994). Review of the literature 
revealed that currently there is no accepted protocol or criteria" for monitoring ototoxicity in 
children, indicating the need to develop a standard monitoring program for this population. 
Institutionalization of Children at Brooklyn Chest Hospital for TB 
The following information was obtained from Dr M Willemse, the paediatrician at Brooklyn 
Chest Hospital to help identify suitable patients for the present study (personal communication, 
August 19,2010). 
Children are admitted to Brooklyn Hospital once they have been diagnosed with TB and 
have begun TB treatment at a referral hospital. At B~ooklyn Chest Hospital a comprehensive 
assessment confirms the diagnosis and type of TB and the relevant treatment is determined. 
Unlike drug susceptible TB, the treatment of drug resistant-TB includes ototoxic drugs. Drug-
resistant-TB is suspected in a child who fails to respond to treatment despite good documented 











Drug resistant TB is confirmed by sputum culture and drug susceptibility testing, which is only 
positive in 30-60% of suspected cases due to the paucibacillary nature of childhood TB. In 
addition, test results may take up to two months, for these reasons and on the basis of the 
physician's advice children with high index of suspicion of MDR-TB contacts are treated for 
drug-resistant TB with amikacin, ofloxacin, isoniazid, pyrazinamide, ethambutol, ethionamide 
prior to laboratory test results. Once the drug susceptibility test results are available, children 
with resistance to amikacin or ofloxacin or both of these second-line drugs will receive 
capreomycin and para- aminosalicylic acid respectively. Drug susceptibility test results may 
show different forms of drug-resistant TB including mono-rifampicin resistant, multi-drug 
resistant, pre-extensively drug-resistant and extensively drug-resistant (XDR). Patients with 
different forms of drug-resistant TB are treated with ototoxic drugs and hence should be closely 
monitored for ototoxic hearing loss (ASHA, 1994). 
When this study was initiated there were no hearing testing protocols for children and the 
hearing screening tests were not performed routinely at Brooklyn Chest Hospital. It is only 
during the course of this study that the ototoxicity monitoring has been established at the 
hospital. 
Hearing evaluation. The following protocol was obtained from Dr M Willemse, the 
paediatrician and Miss K Jacobs, senior audiologist at Brooklyn Chest Hospital in order to get 
familiar with the hearing evaluation process in this institution (personal communication, August 
19,2010). 
Children receiving ototoxic medication are referred to the resident audiologist for hearing 











emissions (for younger children) or air conduction audiometry (for older children) are 
implemented almost every 2 weeks. Since children initially receive the ototoxic medication from 
the referring hospital/clinic, where hearing tests are not routinely performed, there is no baseline 
hearing evaluation that could be compared to the test results for earlier detection of ototoxicity. 
Patients with test results that indicate hearing loss are referred to the attending physician for an 
alternative treatment with potentially less ototoxic drugs, which may prevent further hearing 
loss, particularly in speech frequencies. Children who require hearing aids are referred to 
audiologists at Tygerberg or Red Cross Hospitals, and those with middle ear abnormalities are 
referred to the attending physician. Children with middle ear abnormalities which require special 
care (children whose middle ear pathologies persist following the physician's intervention) are 
referred to an Ear, Nose and Throat specialists at Tygerberg or Red Cross Hospitals. 
The current study reports on the nature and frequency of outer and middle ear abnormalities and 
hearing loss in institutionalized children at Brooklyn Chest Hospital receiving ototoxic 
medication for TB. The purpose is to alert the relevant health care authorities of the possible 
effects of ototoxic drugs and institutionalization on hearing of children with TB and to 
emphasize the need for a routine ototoxicity monitoring prgramme in this population. 
The Impact of Hearing loss in Children 
The severity of the impact of hearing loss in children depends on various factors; the most 
important ones being the degree, laterality, configuration and time of onset of hearing loss 
(probst, 2006, Knight, 2008). Childhood hearing loss as it was mentioned earlier has a significant 
impact on the development of receptive and expressive communication skills (speech and 











their normal peers and as they grow older the gap between their vocabulary and those with 
normal hearing increases (Johnson, Benson & Seaton, 1997; Northern & Downs, 2002). In 
addition, hearing impaired children have difficulty understanding grammar, word order, words 
with multiple meanings and idioms (Johnson et al., 1997; Northern & Downs, 2002), which 
adversely influences their academic achievement. Poor academic achievement is seen as early as 
the first grade and learning problems become more severe when the child enters second or third 
grade (Khiri Md Daud, Noor, Rahman, Sidek & Mohamad, 2010; Nelson, 1997). Children with 
hearing loss have difficulty in reading, writing and mathematical reasoning (Khiri Md Daud et 
al., 2010; ASHA, 2010). Hearing loss can also negatively influence a child's cognitive, social and 
emotional development (Adams & Rohring, 2004; Ansari, 2004). Children with hearing loss are 
often unsuccessful in social activities and are usually unhappy in the school environment or other 
social gatherings (ASHA, 2010; Rall, 2007). Any undetected or unmanaged hearing loss in 
children could affect their behaviour and quality of life (Olusanya, 2000). Anxiety, depression 
and attention problems are common behavioural problems in hearing impaired children (Gouma 
et al., 2011). In adulthood, hearing impaired individuals may face various problems in obtaining, 
performing and keeping a job (Copley & Friderichs, 2010), thus unemployment rate, low wages 
and fewer full-time job opportunities are higher among this population (Punch, Hyde & Creed, 
2004). In essence, hearing loss in children especially in those who are at the age of speech and 
language development could have disastrous consequences, since hearing loss may cause delays 
in speech and language development, schooling difficulties (literacy), social and emotional 
disorders with resultant poor quality of life (Northern & Downs, 2002; Neuwelt & Brock, 2010). 
The negative consequences of childhood hearing loss indicate the need to assess the 











profound hearing loss and even deafness. Such information will allow early identification of 
ototoxic hearing loss and the opportunity to prevent or minimize further hearing loss in 
frequencies critical for speech, by administrating an alternative less ototoxic agent (Fausti et aI., 
2007; ASHA, 1994). Moreover this information will be valuable for planning for service 
delivery to this population (e.g. provision of hearing aids for those who already have hearing loss 













To describe the auditory function of participants with TB between the ages of 0 (from the time of 
birth) and 18 years who are receiving ototoxic drugs at Brooklyn Chest Hospital. 
Objectives 
In participants at Brooklyn Chest Hospital who are receiving ototoxic medication for TB: 
1. To detemrine the prevalence of outer and middle ear abnonnalities pre and post medical 
intervention: 
1.1. Outer ear 
1.2. Middle ear 
1.2.1. Appearance of the tympanic membrane 
1.2.2. Funtion of the meddle ear as detemrined by: 
1.2.2.1. Impedance and admittance 
1.2.2.2. Ipsilateral acoustic reflexes 
1.2.3. Unresolved middle ear abnonnalities 
2. To describe the prevalence and nature of hearing loss 
2.1. Prevalence of hearing loss 
2.2. Nature of the hearing loss 












2.2.3. Laterality and symmetry 
3. To determine the relationship between: 
3.1. Middle ear abnormality and sex 
3.2. Middle ear abnormality and age 
3.3. Duration of hospital stay and middle ear abnormality . 
3.4. Duration of ototoxic drug exposure and the presence of a sensorineural hearing loss 
3.5. Type of ototoxic drug and the presence of a sensorineural hearing loss 
3.6. Type ofTB and 
o Sensorineural hearing loss 
o Middle ear abnormality 
3.7. Comorbid presentation of HN and TB and middle ear abnormality 
3.8. Comorbid presentation ofHN and TB and sensorineural hearing loss 
Research Design 
A descriptive survey research design (Polit & Beck, 2004) was used in this study. Such a design 
examines the situation as it is by identifying the characteristics of the observed phenomena (polit 
& Beck, 2004). The aim of descriptive research is to describe the relationship among variables 
rather than to infer cause and effect relationships, as many research problems are cast in non 
causal terms (pollt & Beck, 2004). A survey design describes the characteristics of a large 











the hearing status of a group of TB children receiving ototoxic medication, a descriptive survey 
research design best facilitated this process. 
Descriptive research is an efficient means of collecting a large amount of data about a 
problem (Polit & Beck, 2004). The major limitation of descriptive research designs is that they 
are weak in their ability to reveal causal relationships (Polit & Beck, 2004). It was not the 




Inclusion criteria. Children who met the following criteria were selected to participate in 
the study: 
• Be between 0 and 17.11 years of age 
• Resident at Brooklyn Chest Hospital 
• Received ototoxic TB medication for a minimum period of 14 days prior to assessment 
Ototoxicity does not generally appear until 5 to14 days after the start of ototoxic treatment 
(de Jager & van Altena, 2002). 
Exclusion criteria. Children who were excluded from the study: 
• Too ill to have hearing tests done (as determined by a physician/nurse). 











Recruitment. Following ethics approval of the study by the University of Cape Town's 
Faculty of Health Sciences and Human Research Ethics Committee, permission was obtained 
from the Provincial Department of Health in the Western Cape and the Medical Superintendent 
at Brooklyn Chest Hospital to: 
1. Review the records of all children at the hospital to identify eligible participants. 
2. Contact the parents of all eligible participants. 
Once permission was granted, the researcher met the parents at the hospital, explained the 
nature of the study to them and obtained written informed consent for the inclusion of their 
children in the study. 
Sampling method. Non probability purposive sampling (Trochim, 2006) was used for 
this survey. In purposive sampling, one samples with a purpose in mind. The sample includes 
one or more specific predefmed groups. In this method one of the first things to do is to verify 
that the respondent does in fact meet the criteria for being in the sample (Trochim, 2006). For 
this study all individuals who met t he selection criteria were included in the study. As a result a 
non probability purposive sampling method best facilitated this study. 
Sample size. The size of the sampling frame was estimated to be 50 by the resident 
audiologist at Brooklyn Chest Hospital. The size of the sample was directly linked to the number 
of eligible participants who were at Brooklyn Chest Hospital at the time of the study. All eligible 
participants were included in the study. While a power analysis typically guides the 
determination of the sample size, this study's sample size was constrained by the size of the 











(the only residential facility in the Cape Town metropole for individuals with MDR TB, who 
would receive ototoxic medication). 
The records of the patients at Brooklyn Chest Hospital were reviewed, with 65 children 
hospitalized for TB from beginning of May to end of August 201 o. Of these children, 32 were 
eligible to participate in the study. Prior to the commencement of the study, one child died and 
one was discharged from the hospital, which left 30 patients to form the basis of the study. Of30 
children who were recruited, one died, one was discharged and one was referred to Tygerberg 
Hospital for severe illness before hearing tests could be completed, with only outer and middle 
ears of these three participants assessed. 
Description 
Research site description. The following information was obtained from the patient 
records and Dr M Willemse, the paediatrician at the hospital (personal communication, August 
19,2010). 
The Brooklyn Chest Hospital (BCH) is the main referral center for patients with TB 
diseases from hospitals and clinics across the Western Cape. It is the only facility that treats 
XDR TB patients in the province and contains 349 beds with 16 children beds and 40 baby cots 
which are usually filled to capacity. Children treated at BCH may be hospitalized for periods 
ranging from 6 months to 3 years. The hospital has a school on site with 30 to 40 pupils. The 
majority of patients admitted to Brooklyn Chest Hospital are poor and are African or Coloured. 
Participant description. The mean age of the participants (n=30) was 7 years (85.7 
months) and ranged from seven months to 16.6 years. There were nine participants in the 0 to 3 











participants in the 7 to 18 years age group (group III). The distribution of the participants 
between the two sexes was almost equal and there were 16 (53.3%) females and 14 (46.6%) 
males. 
The majority of the participants (n = 25, 83.3%) had pulmonary TB. The frequency of TB 
meningitis was 10% (n = 3), disseminated TB 3.3% (n = 1) and TB of hip joint 3.3% (n = 1). 
Forty percent (n = 12) of the participants were HIV -positive. 
Drug-resistant-TB was confirmed in 20 participants with a diagnosis ofMDR-TB (n=14), 
XDR-TB (n=4) and mono-rifampicin resistant TB (n=2). Drug-resistant-TB was suspected in 10 
participants with a diagnosis of probable MDR-TB (n=8) and XDR-TB (n=2). The TB treatment 
regimen included, amikacin in 83.3% (n =25), capreomycin in 13.3% (n = 4) and streptomycin in 
3.3% (n = 1) of participants. The mean duration of the participants' hospital stay (up to the date 
of the study) was 28 weeks (with a range of 6 to 92 weeks). The length of treatment with 
ototoxic drugs before commencement of hearing tests ranged from 6 to 92 weeks, with a mean 
time of 27 weeks. Participants had TB treatment prior to their stay at Brooklyn Chest Hospital, 
the duration and nature of which could not be determined since records were not available. 
One of the participants in group III (7-18 years) was developmentally delayed with 
'hemiplegia, the hearing status of whom was determined using OAE and AABR. See Appendix A 
for the participants' characteristics. 
Data Collection 
Test protocol. The use of a single test for assessing a child's hearing sensitivity is not 
recommended (Diefendorf, 2009). Based on the complex nature of the auditory mechanism, 











audiologist to reach a more confident diagnosis (Diefendorf, 2009). In test battery selection, the 
researcher selected the most cost effective tests for which validity and reliability are the highest. 
Table 1 
illustration of the Test Protocol and Equipment Used to Assess Auditory Function in Different 
Age Groups 
Age groups of participants Tests Equipment 
Test environments Quest Technologies 2700 -sound 
level meter 
Otoscopic examination Heine Minilux 2000- otoscope 
All age groups Tympanometric examination OSI 38- immittance instrument 
Interacoustic AT 235H 
Acoustic Reflex examination OSI 38- immittance instrument 
DPOAE examination OSI audio screener 
AABR examination OSI audioscreener 
Participants ~ 3yr Diagnostic ABR examination OSIAudera 
ASSR examination OSIAudera 
3yr < participants ~ 7yr Play Audiometric MA51- audiometer 
examination 
7yr <participants < 18yr Audiometric examination MA51- audiometer 
Note. DPOAE=Distortion Product Otoacoustic Emissions. AABR=Automated Auditory 
Brainstem Responses. ABR=Auditory Brainstem Responses. ASSR= Auditory Steady-State 
Responses. 
Equipment. All equipment had been calibrated within the last six months, in accordance 
with the manufacturer's specifications. 
Test Environments 
1. Sound treated booth (ANSI S3.1 1999, Audio Sound Rooms) 
2. Quiet environment: An acceptable low level of noise is under 50 dB SPL (ANSI 











since the Participants were examined in a sound proof audiobooth for pure tone 
audiometric, OAB and AABR examinations there was no need to utilize a sound level 
meter. 
Heine Minilux 2000- otoscope. The otoscope is designed for the visual examination of 
the external auditory meatus and tympanic membrane (Stach, 2008). This implement was used in 
the study to visually examine the status of the outer ear and tympanic membrane. 
GSI38-immittance instrumentllnteracoustic AT 235H. The immittance instrument is 
used to determine the mobility and impedance of the tympanic membrane by measuring the 
sound pressure reflected, thereby providing information on the status of the tympanic membrane, 
middle ear cavity, Eustachian tube, stapedius muscle and the VII and the VIII cranial nerves. 
This instrument is used to obtain a tympanogram and to determine the threshold or the presence 
of an acoustic reflex (Frank & Rosen, 2007). 
1. Tympanogram: A tympanogram is a measurement of acoustic admittance at the 
tympanic membrane as a function of ear canal's air pressure (Frank & Rosen, 2007). 
Stimulus characteristics: 
1. Probe tone frequency: children < 7 months of age =1000 Hz, 
children> 7 months of age = 226Hz 
2. Air pressure: +200 to -400 daPa 
Since the GSI 38-Immittance Instrument could not produce a 1000 Hz tone, Interacoustic 











instrument was never used in the study, since none of the participants were under 7 months of 
age. 
2. Acoustic Reflex: acoustic reflex is a measure of stapedius muscle contraction to a pure 
tone stimulus via the probe (Frank & Rosen, 2007). 
Stimulus characteristics: 
1. Stimulus type: Pure tone 
2. Frequencies: 500, 1000, 2000 and 4000 Hz 
3. Intensity range: 0 to 105 dB HL 
In this study, the immittance instrument was used to accurately assess the status of the 
middle ear and tympanic membrane. Since OSI 38-Immittance Instrument is only equipped with 
ipsilateral stimuli, contralateral acoustic reflexes could not be determined. 
MA51-audiometer. The audiometer measures the hearing sensitivity and delivers the 
calibrated suprathreshold stimuli (Stach, 2003). 
Pure tone audiometry: It is used to detennine the hearing threshold and type of hearing 
loss (sensorineural or conductive) via air and bone audiometry. With air conduction audiometry 
the stimulus to the ear canal is delivered via headphones. With bone conduction audiometry the 
stimulus to the cochlea is delivered by vibrational energy transmitted through the skull from a 
transducer (vibrator) that is placed on the mastoid (Hinchcliffe, 2003). 
Stimulus characteristics: 











2. Frequencies: Air conduction = 250, 500, 1000, 2000, 4000, 8000 Hz; 
Bone conduction = 250, 500, 1000, 2000, 4000 Hz 
3. Intensity range: Air conduction = -10 to 120 dB HL 
Bone conduction = 0 to 70 dB HL 
GSI audioscreener. The GSI Audioscreener is an effective screening tool m the 
evaluation of hearing in newborns and small children. The instrument includes two tests: 
1. DPOAE (Distortion Product Otoacoustic Emissions): This test is used to assess 
cochlear integrity by measuring the physiologic response of the outer hair cells to 
acoustic stimuli. During DPOAE, the audio screener generates tonal stimuli, and the 
acoustic energy produced in response to the clicks is detected by a microphone within the 
probe (Ceranic, 2003). 
Stimulus characteristics: 
1. Stimulus type: tonal stimuli 
2. Test frequency: 2000, 3000 and 4000 Hz (Roeser, Clark, 2004) 
3. Intensity range: 45 to 70 db SPL 
4. Ratio off2/fl: 1.2 
This study utilized distortion product otoacoustic emissions to assess the integrity 











noise made by the patient, and have a wider frequency range than Transient Evoked 
Otoacoustic Emissions (Hall, 2000). 
2. AABR (Automated Auditory Brainstem Responses): This test is used to measure the 
integrity of the inner ear and the auditory pathway to the level of the brainstem (Hamilton-
Craig, 2003). The click stimulus is presented via an ear canal probe, and the 
electrophysiological brain-stem responses are detected by scalp electrodes. Average 
responses from a large number of stimuli are used by automated screener to produce a final 
result (Hamilton-Craig, 2003). 
Stimulus characteristics: 
1. Stimulus type: Click 
2. Stimulus range: 500-4000 Hz 
3. Intensity range: 35-40 dBnHL 
4. Stimulus rate: 37 per second 
Click stimuli, because of their rapid onset and broadband spectrum, elicit a neural 
response from a large number of auditory neurons almost synchronously and therefore, 
are most likely to produce a robust response when measured from the scalp (Sininger & 
Hyde, 2009). Thus click stimuli have been chosen for this test. 
Quest Technologies 2700 -sound level meter. A sound level meter is a basic instrument 
for determining noise levels (Gelfand, 2009). The presence of ambient noise above 50 dB SPL 











considered to use a sound level meter in the study to determine the level of noise present at 
hearing assessment sites. 
Sound Level Meter characteristic: 
1. Unit of measure: dB SPL 
2. Frequency weighting networks: A. The 'A' weighting setting emulates the response of 
the human ear at low levels and is used for most industrial and community noise 
measurements (Quest Technologies 2700 SLM user manual). 
3. Response: Slow (l second time constraint). 
4. Reference frequency: 1 kHz 
5. Frequency range: 4 Hz to 50 kHz 
6. Accuracy: Within 0.7 dB SPL 
GSI Audera. An electrical instrument which provides objective information to estimate 
hearing sensitivity and to identify neurological abnormalities of auditory nerve and the auditory 
pathway up to the brainstem (Don & Kwong, 2009). The hearing thresholds of participants 
younger than 3 years of age who were suspected of having hearing loss (from the results ofOAE 
and AABR tests) were considered to be determined using this instrument which conducts two 
tests: 
1. ABR (Auditory Brainstem Responses): ABR audiometry is detection of an evoked 
potential generated by a brief click or tone burst transmitted from an acoustic 











surface electrodes placed in the vertex and each ear lobes or mastoid. The output of 
the electrodes is averaged and charted against the time (millisecond). The resultant 
waveform is characterized by seven peaks. These waveforms normally occur in a 
period of 10-millisecond period after the onset of the stimulus (Burkard & Don, 2007; 
Sininger, 2007). 
Stimulus characteristics: 
1. Stimulus type: Click stimuli and tone burst 
2. Frequency range for tone burst: 500 to 4000 Hz 
3. Stimulus rate: 33.1 per second (for threshold), 11.1 per second (neurological) 
4. Intensity range: 20 to 90 dBnHL 
2. 80-Hz ASSR (Auditory Steady-State Responses): The auditory steady-state response 
(ASSR) refers to an electrophysiologic response to rapid auditory stimuli which creates 
an estimated audiogram. Auditory Steady-State Responses are recorded from electrodes 
taped on the forehead and each mastoid (or ear lobe) while the person listens to tones of 
varying frequency and intensity via earphones (Aoyagi, Watanabe, Ito & Abe, 2007). 
80-Hz ASSR was chosen for this test because 80-Hz ASSR, or high frequency ASSR, is 
applicable to sleep children (Aoyagi et al., 2007). 
Stimulus characteristics: 
1. Stimulus type: Tone 











3. Intensity range: -10 to 127 dB HL 
Validity and reliability. The validity and reliability of the tests used in this study are 
well established in every day practice and further outlined by sensitivity and specificity of the 
data presented in the table below. 
Table 2 
The Sensitivity and Specificity of the Tests Used to Assess the Integrity of the Auditory Pathway 
Tests Sensitivity Specificity Assessment Limitation Solution Reference 
region 
Tymp 90% 75% TM Can't be done Refer + Onusko, 
,problems when repeat 2004 
wax! discharge once they 
Eresent cleared 
AR 95% 50% ME Lack of contra Use of Northern & 
problems reflex test Downs, 
battery 2002 
PTA 74.4% 92.1% Hearing loss Diagnosis of Use of Forster & 
MEE test Kumar, 
battery 1997 
OAB >97.5% 94% Cochlear Diagnosis Use of Steam & 
problems neuralHL AABR Swanepoel, 
2007 
AABR 100% 96-98% Hearing loss Diagnosis of Use of Bhattachary 
MEE test ya,2009 
battery 
ABR >90% 90% Hearing Diagnosis of Use of Bhattachary 
loss MEE test ya,2009 
battery 
ASSR 100% 51% Hearing Diagnosis of Use of Santiago-
loss MEE test Rodriguez, 
battery et al., 2005 
Note. AC=acoustic reflexes. Tymp=tympanometry. PTA=pure tone audiometry. HL= hearing 











Study personnel. An audiology undergraduate student who was familiar with test 
procedures and fluent in the English, Afrikaans and IsiXhosa languages was recruited to explain 
the instructions in the language appropriate to the participant. However, there was no need for 
the translator, since all of the participants could speak either English or Afrikaans and the 
resident audiologist at Brooklyn Chest Hospital, who could speak both languages, assisted the 
researcher in this regard. 
Procedure. The researcher registered with the Health Profession Council of South Africa 
(Appendix B). Ethical approval was obtained from the University of Cape Town's Faculty of 
Health Sciences Research Ethics Committee (REC Reference Number: 010/2010) and Provincial 
Health Research Committee (Reference Number: RP40/2010), (Appendix C & D). The Medical 
Superintendents of Brooklyn Chest Hospital gave verbal permission to the researcher to conduct 
the research at Brooklyn Chest Hospital. Informed written consent was obtained from 
parents/legal guardians and assent from participants who were old enough to make descisions, 
before commencement of the study (Appendix E). The informed consent forms were available in 
English, Afrikaans and isiXhosa (Appendix F, G & H). A flow diagram of the steps involved in 
obtaining ethical approval and consent from parents/participants is provided in appendix I. 
A hard copy of the tympanometric and acoustic reflex examinations results could not be 
made due to lack of a compatible printer. Moreover, it was not possible to save the audiometric 
examination results on the researcher's computer (no compatible cable) and the researcher 
manually recorded the results of all hearing examinations. In all test procedures, each ear was 











A real- time analysis and interpretation of the results were provided for each step of the 
procedure as this had a significant impact on decision making and the next step of the procedure. 
A flow diagram of the procedure is provided in Appendix 1. 
Otoscopic examination: A visual inspection of the outer ear, middle ear and tympanic 
membrane was carried out using the otoscope. Participants with visible dermatological 
conditions of the pinna, impacted wax in ear canal, tympanic membrane micro-perforations or 
active middle ear infections were referred to a Physician at Brooklyn Chest Hospital. Upon 
completion of their treatment, which entailed 2 weeks to 3 months of therapy (depending on the 
nature of the pathology) the participants' ears were otoscopic ally examined again. Participants 
who failed for the second time were referred to TygerberglRed Cross Hospital by the physician. 
Participants who passed the otoscopic examination were then assessed further (Tympanometry). 
Tympanometric examination: The status of the middle ear and tympanic membrane was 
assessed using the immittance instrument. The participant was instructed to keep quiet and sit 
still during the examination. The test was performed by inserting a clean rubber-tipped probe 
with suitable size and shape into the ear canal. The OSI 38-immittance instrument changed the 
pressure (from +200 to -400 daPa) in the ear, produced a pure tone (226 Hz), and measured the 
tympanic membrane responses to the sound at different pressures. The results were depicted in a 
tympanogram, which was displayed on the unit's screen (Clark et aI., 2007). 
The probe frequency for children older than 7 months of age was adjusted to 226 Hz. 
This value would have been adjusted to 1000 Hz had any of the participants been younger than 7 
months of age, which was not the case (Baldwin, 2006). The results were manually recorded and 











Type A tympanogram (-100 < peak values < +100 daPa, O.3cc <SC < 1.6cc, ECV < 2cc) 
was considered nonnal (Jerger, 1970; Lliden, 1969, as cited in Shanks & Shohet, 2009), which 
indicates the presence of a nonnal pressure in the middle ear with natural mobility of the 
eardrum and the ossicular chain (Gelfand, 2001). Type B (no peak values, SC = Occ, ECV = or> 
2cc) or C (peak values < -100 daPa, O.3cc < SC< 1.6cc, ECV < 2cc) tympanograms (Jerger, 
1970; Lliden, 1969, as cited in Shanks & Shohet, 2009) may indicate the presence of fluid in the 
middle ear, scarring of the tympanic membrane, lack of contact between the ossicular chain of 
the middle e~ or a tumor in the middle ear (Gelfand, 2001). If abnonnal results (type B or C 
tympanograms) were obtained, the test was reimplemented for confinnation of the results. The 
probe tip was removed for cleaning after tympanometric examination of each ear. 
Type B tympanogram also occurs when a probe is sealed against the canal wall and type 
C tympanogram occurs in the presence of a negative middle ear pressure. Since a hennetic seal is 
required for obtaining acoustic reflexes in ears with middle ear pathology and negative pressure 
(Shanks & Shohet, 2009), an acoustic reflex test following tympanometry determines the definite 
type of tympanograms. Moreover, diagnostic infonnation from immittance measures are 
strengthened when results from both procedures (AR and tympanogram) are interpreted together 
(Clark et aI., 2007). Thus all participants with type A, B and C tympanograms proceed to the 
next step of the procedure (Acoustic Reflex). 
Acoustic Reflex examination: This test was performed using the GSI 38-immittance 
instrument by inserting a rubber-tipped probe in the ear canal that presented sound stimuli (at 
intensities of 85 to 105 dB HL) at 500, 1000, 2000 and 4000 Hz for Ipsilateral reflexes. The 











Participants with absent ipsilateral acoustic reflexes but normal tympanograms (Type A) 
required further audiologic investigations prior to medical referral and proceeded to the next step 
(hearing assessment). Participants with Type B or C tympanograms, and with absent acoustic 
reflexes, were referred to the physician at Brooklyn Chest Hospital. Upon completion of their 
treatment, which entailed 2 weeks to 3 months of therapy depending on the nature of the 
pathology [e.g. those with chronic otitis media or otitis media with effusions required much 
longer and more complicated treatment (Margolis & Hunter, 2000)], the participants were 
retested using the immittance instrument. Participants under 3 years of age, whose condition 
remained unresolved, were referred to an Ear, Nose and Throat specialist at Tygerberg/Red 
Cross Hospital by the physician. The rest of the participants proceeded to the next step, in which 
they were tested with equipment appropriate to their age. They were divided into the following 
age groups: 
A) Participants under 3 years of age: 
It should be mentioned that participants with cognitive impairment (who were older than 3 years 
of age) or who were uncooperative were also assessed using this procedure. 
DPOAE examination: In this step the function of the outer hair cells of the inner ear was 
assessed using distortion product otoacoustic emissions (DPOAE) technology. During DPOAE 
screening, the audiologist placed a small probe in the ear canal that is designed to deliver the 
sound stimuli and also to collect a response via a sensitive receiving microphone. In a healthy 
ear, sound stimuli from the probe are transmitted through the middle ear to the inner ear where 
outer hair cells of the cochlea respond by producing an emission. This emission was picked up 











on the unit's screen (Swanepoel, Ebrahim, Joseph & Friedland, 2007). If a "pass" test result for 
each frequency was obtained, the overall result was a "pass" too. The results were manually 
recorded by the researcher. 
The test results read "refer" if there was an impaired cochlea that was not responding 
normally to sound. For purposes of this study, an additional error message, "can't test", was 
generated by the equipment due to internal noise generated by the participant's movement. If the 
participant continued to move and did not settle at all, the researcher re-tested himlher later at a 
more appropriate time. 
This test was completed in less than 5 minutes and participants with "pass" or "refer" 
results proceeded to the next step of the procedure. Participants with refer results would have 
also proceeded to the next step, AABR examination, in order to obtain more information about 
their hearing status, prior to referral for audiology services (which was not the case). 
AABR examination: Participants who were tested with DPOAE were also tested by 
automated auditory brain responses (AABR) to assess their auditory function from the eighth 
nerve through the auditory brainstem. AABR measurements were obtained by placing disposable 
surface electrodes high on the forehead, and on the mastoids after these anatomical areas were 
cleaned adequately so that the maximum impedance difference between the two electrodes was 
less than 5 k Ohms (Maruthy & Mannarukrishnaiah, 2008). The click stimulus (at 35-40 dBnHL) 
was delivered to the participant's ear via a small earphone designed to attenuate background 
noise. The AABR system compared a participant's waveform with that of a template developed 











comparison and was displayed on the unit's screen. The results were recorded manually by the 
researcher. 
Participants who did not pass AABR or AOAE were to be referred for audiology services 
at TygerberglRed Cross Hospital for detennination of their hearing thresholds (diagnostic AB R 
and ASSR tests) by the resident audiologists. However all participants passed the DPOAE and 
AABR tests and no one was referred for the ABR and ASSR tests. 
ASSR examination: 80-Hz ASSR is used to create statistically valid audiograms. ASSR 
examination is done by placing electrodes taped on the forehead and each mastoid/earlobe, after 
these anatomical areas are cleaned adequately so that the maximum impedance difference 
between the two electrodes becomes less than 5 k Ohms (Hatton & Stapells, 2011). This test, 80-
Hz ASSR, is performed under sedation or in natural sleep if the participant is under 6 months of 
age. Stimulation of a repetitive sinusoidal amplitude/frequency (AMlFM)-modulated tone is 
delivered using earphones. The results are detected objectively using statistical formulas that 
determine the presence or absence of a true response (Aoyagi et aI., 2007). 
Diagnostic ABR examination: This test estimates the hearing sensitivity by placing 
disposable surface electrodes high on the forehead, on the mastoid, and on the nape of the neck 
after these anatomical areas are cleaned adequately so that the maximum impedance difference 
between the two electrodes becomes less than 5 k Ohms (Maruthy & Mannarukrishnaiah, 
2008).The participant should be sleep for the duration of the test. Participants under the age of 
six months are not sedated, and the test is performed while the participant is naturally sleeping, 
following a feeding. Participants over the age of six months are sedated by an anaesthetist with 











the electrodes measure the electrical activity from the auditory pathway. These electrical 
responses are analyzed by the computer and produced a waveform. The different peaks on the 
resulting waveform provide information on the time it takes various structures of the auditory 
pathway to respond following the stimulus. The results are interpreted by an audiologist to 
estimate the hearing thresholds (Bhattacharyya, 2009). 
These procedures (ABR and ASSR) are in accordance with the routine hearing tests 
performed at TygerbergiRed Cross Hospital. The total testing time is approximately 1.5 hours 
with 30 minutes reserved for sedation recovery time. 
B) Participants between 3 and 7 years of age: 
Ploy Audiometric examination: In this step the degree and type of hearing loss (sensorineural or 
conductive) were determined using pure tone audiometry. In Play audiometric examination a 
participant's hearing is assessed in decibels (dB HL) with a calibrated audiometer. Both air and 
bone conduction were tested at frequencies between 250-8000 Hz and 250-4000 Hz respectively 
in a sound proof audiobooth. During play audiometry the participant is conditioned to engage in 
an activity, such as putting rings on a spindle or putting together simples puzzles, each time the 
signal is heard. The participant was then introduced into a sound proof audiobooth and the 
researcher placed a headphone that was completely centred over the ear canals. The participant 
was taught to wait, listen and only respond with the play activity when the auditory signal was 
heard. The initial test frequency was 1000 Hz at 30 dB HL. When the participant failed to 
indicate the presence of a tone, the sound intensity was increased at 10 db HL increments until a 
response was obtained indicating that a tone was heard The intensity was then decreased by 5 











was recorded as the threshold. The pure tone thresholds for each ear were obtained, in order of 
2000, 3000, 4000, 6000, 8000, 1000, 500 and 250 Hz (American National Standards Institute, 
2004). The inter-octave measurements were also made whenever there was a difference of 20 dB 
or more between two adjacent octave frequencies (ASHA, 2005). The same procedure was used 
to determine bone conducted thresholds, except that a bone vibrator was placed on the mastoid 
processes and thresholds were obtained at a frequency range of 250 to 4000 Hz (Diefendorf, 
2009). Masking was used for both, air conducted and bone conducted when indicated it was 
appropriate to do (ASHA, 2005). 
In order to minimize habituation, maintain a participant's attention and maximize 
repeated response behavior, attractive stickers were given to the participants at appropriate times, 
as a form of reinforcement (social praise). Hearing thresholds at audiometric level of lower than 
16 dB HL, at all test frequencies, from 125 Hz to 8000 Hz with air-bone gap of ~ 10 dB for both 
ears was considered normal hearing sensitivity (Duggal & Sarkar,.2007; Schlauch & Nelson, 
2009). The hearing thresholds were recorded on audio grams by the researcher. Participants who 
failed this step were referred to the audiologist and the physician at the hospital for further 
audiological testing and possible alternative less ototoxic treatment. 
C) Participants between 7 and 17.11 years of age: 
Audiometric extl1IIination: In this step the same procedure described in play audiometry 
was used to determine the air and bone conduction thresholds of the participants, with the 












The services of a statistical consultant were utilized in analysing the data. In order to determine 
the prevalence of outer ear abnormalities, the data obtained from the otoscopic examination of 
the outer ear were analysed via frequency counts since all the information was categorical data 
(Howell, 2007). With categorical data, the data consists of totals or frequencies for each category 
and thus frequency counts were the best statistical method to extrapolate information (Howell, 
2007). 
The outcomes of the otoscopic, tympanometric and acoustic reflex examinations (Table 
3) were analysed via frequency counts to ascertain the prevalence of middle ear abnormalities. 
The presence of mixed hearing loss or air bone gap was determined in order to confirm abnormal 
middle ear function of ears with no acoustic reflexes but with normal otoscopic and 
tympanometric results. 
Table 3 
Determination of the Normality and Abnormality of Middle Ear 
Middle ear Examination results 
Normal Normal otoscopic result + Type A tymp + present Ipsi AR 
Abnormal 
Normal otoscopic result + Type A tymp + Absent Ipsi AR + 7th nerve injury 
Normal otoscopic result + Type A tymp + Absent Ipsi AR + Mixed HUABG 
NormaVabnormal otoscopic result + Type B/C tymp + Absent/present Ipsi AR 
PerflGrommet3 
Note. ME=middle ear. Perf= perforation. ABG= air-bone gap. HL=hearing loss. AR = acoustic 
reflexes. Tymp=tympanogram. 
3 Tympanometric and acoustic reflex examinations on ears with grommet or perforations of the 











In order to determine the prevalence of unresolved middle ear abnormalities, the number 
of ears with middle ear abnormality before and after referral for medical intervention was 
compared using the Generalized Linear Models. Generalized Linear Models are an extension of 
the linear modeling process which analyzes dependent variables with non-normal distributions 
and for many link functions other than identity (Hardin & Hilbe, 2007). Wald Chi-Square is used 
to test the Generalized Linear Models (Hardin & Hilbe, 2007). The probability distribution was 
binomial (which was a non-normal distribution), since the dependent variable was middle ear 
abnormality that could be normal or abnormal, and the link function was logit (not identity). 
Thus Generalized Linear Models were the best statistical method to extrapolate information with 
the 0.05 level of significance (Hardin & Hilbe, 2007). 
Data obtained from pure-tone audiometric or OAE and AABR examinations (Table 4) 
were analysed via frequency counts to determine the prevalence of hearing loss. It should be 
mentioned that, a "Pass" DPOAE or AABR result which is considered normal hearing, means 
that the hearing thresholds were less than 30 dB HL (Sininger, 2007; Prieve, 2008). 
Table 4 
Determination of Hearing Status 
Audiometric DPOAE AABR 
examination examination examination 
(screening test) (screening test) 
Normal hearing Thresholds ~ 15 dB HL Pass Pass 
(0.25-8 kHz) 
Abnormal hearing Thresholds> 15 dB HL Refer Fail 
(0.25-8 kHz) 












Adapted from "Hearing and deafness" (p.63), by P. V. Paul and G. M. Whitelaw, 2010, Sudbury, 
MA: Jones and Bartlett Publisher. 
Data obtained from the type, configuration (Table 5) and degree (Table 6) of hearing loss 
were analysed via frequency counts to describe the nature of hearing loss. The degree of hearing 
loss for participants who passed OAE and AABR was considered within normal limits. 
Table 5 




High frequency loss 
4-SkHz 
> 15 dB HL 
Low frequency loss 
0.125 - 1 kHz 
> 15 dB HL 
Flat loss 
0.25 - 3 kHz & 4 - S kHz 
> 15 dB HL 
Note. HFL= high frequency loss. LFL= low frequency loss. Flat= flat Hearing loss. AC= air 
conduction. 
Adapted from "Audio logic monitoring of multi-drug resistant tuberculosis patients on 
aminoglycoside treatment with long term follow-up" by P. Duggal and M. Sarkar. 2007. BMC 
Ear, Nose and Throat Disorders, 7,1-7. 
The degree of hearing loss was determined using the Northern and Downs (2002) 
classification system based on pure tone averages of 0.5, 1 and 2 kHz. In this classification 
system, the degree of hearing loss for ears with high frequency loss is considered within the 
normal range. In the present study a great number of ears with their degree of hearing loss 
within the normal range (according to the mentioned classification system) had high frequency 











this population, the average of the thresholds for high frequencies (4 & 8 kHz) were also 
calculated (using the same classification system). 
Table 6 
Determination of the Degree of Hearing Loss Based on the Northern and Downs classification 
and the adapted proposed Classification 
Classification 
Northern & Downs C 





Moderate Severe Profound 
30-50 50-70 70+ 
Proposed C 0-15 15-25 25-30 30-50 50-70 70+ 
(PTA of high F) 
Note. PTA of speech F= pure tone average of speech frequencies (0.5, 1 and 2 kHz). PTA of high 
F= pure tone average of high frequencies (4 and 8 kHz). C= classification. 
Adapted from "Hearing in children" by J. L. Northern and M. P. Downs (p. 22). 2002. 
Philadelphia: Lippincott Williams & Wilkins. 
The affect of sex, age and duration of hospitalization on middle ear abnormality were 
analysed using Generalized Linear Models (Hardin & Hilbe, 2007). It was not possible to assess 
the relationship between duration of ototoxic drug exposure and sensorineural hearing loss, due 
to lack of information about the nature of the TB treatment the children received prior to 
admission to Brooklyn Chest Hospital. Statistical analysis of the relationship between the type of 
ototoxic drugs and sensorineural hearing loss was not feasible because of the small sample size. 
It was also impossible to evaluate the link between type of TB and sensorineural hearing loss! 
middle ear abnormality, due to low prevalence of different forms of TB other than pUlmonary 
TB. A comparison was made using Generalized Linear Models, between the ears of participants 
diagnosed with HIV & TB versus those with TB only, to determine the effect of comorbid 











between sensorineural hearing loss and comorbid presentation of HIV and TB were also 
analysed using Generalized Linear Models (Hardin & Hilbe, 2007). 
Ethical Considerations 
Prior to commencement of the study ethics approval was obtained from the University of Cape 
Town's Faculty of Health Sciences Human Research Ethics Committee (REC Reference 
Number: 010/2010, Appendix C) and the Provincial Health Research Committee (Reference 
Number: RP40/2010, Appendix D). The following ethical principles were considered and 
adhered to in accordance with the Declaration of Helsinki (World Medical Association, 2008) 
Autonomy. Parents/guardians of the children were informed both verbally and in writing 
about the aims and nature of the study and what was expected of their children. They were given 
the opportunity to ask questions and seek clarification prior to signing the informed consent 
form. 
Informed consent (written) was obtained from each participant's parent by the researcher 
(Appendix C & D) prior to including them in the study. Once parental consent was obtained, the 
researcher sought verbal assent from each participant (if the participant was old enough) and 
their wishes respected. 
All participants and their parents were verbally and in writing informed of their rights to 
voluntary participation in the study and to withdraw their participation at any time once the study 
has begun, without their treatment being affected in any way. 
Confidentiality. All participants were assigned a research number and data were 











treated as confidential by the translators, the researcher and her supervisors. The participant's 
hospital records and the results of the hearing tests were handled with caution, and were not 
disclosed to anyone other than the healthcare professionals working with the child. All the 
parents of participants were informed in the information letter that their child will not be 
identified in any way in any publications arising from the study. 
Non-maleficence. The hearing tests at Brooklyn Chest Hospital were non-invasive, non-
painful and part of routine care and did not cause any harm. The study was designed in such a 
way that there were none/minimal risks involved in participation. 
For participants less than three years of age who were considered for referral to Red 
Cross Hospital for additional audiometric examinations under sedation, there was a potential risk 
of not recovering from the sedative effect but this is a very rare event and has not occurred in the 
Cape Town area in the last 20 years (Professor S. Singh, personal communication, September 10, 
2009). This test is the usual method to diagnose hearing loss in children less than three years of 
age. The benefit of early diagnosis and intervention is thought to outweigh possible risks of the 
procedure. However, the risk is significantly reduced by the presence of experienced 
physicians/nurses. This information was conveyed in the consent form. 
Beneficence. At Brooklyn Chest Hospital the children's auditory status is monitored at 
monthly intervals, where possible. However, due to the high workload of the resident 
audiologist, regular testing is not always possible. The participants of the present study received 
a comprehensive auditory assessment, which could identify peripheral auditory problems. 











Justice. All participants were treated fairly during all stages of the study and they were 
able to benefit from the outcomes of the research as indicated above. 
Professional Competence. The researcher is an Audiologist with 3 years of work 












The results are described in accordance with the aim and objectives of the study. Since the 
auditory status of two ears of a participant can be different, in the present study the results of the 
ears are reported and not of the participants. A summary of the results is presented at the end of 
each relevant section. The results described the auditory function of children with TB between 
the age of 0 and 18 years who were receiving ototoxic drugs at Brooklyn Chest Hospital. 
1.1. Prevalence of outer ear abnormalities pre and post medical intervention 
The results of the otoscopic examination of the 58 ears (29 participants), prior medical 
intervention, revealed that the participants had no structural abnonnalities, foreign objects, 
growths or infections of the outer ear. Impacted wax was observed in 12% of ears (n = 7, 14% of 
participants) and was successfully cleared following management. Three out of four participants 
with impacted wax had bilateral presentations. 
1.2. Prevalence of middle ear abnormalities pre and post medical intervention 
The appearance and function of the tympanic membrane and the middle ear are described in the 
following sections. 
1.2.1. Appearance of the tympanic membrane 
Post the removal of impacted wax which had occluded the ear canal, otoscopic examination of 
the 58 tympanic membranes revealed 14% (n = 8, 21% of participants) with abnonnal 
appearance. Four participants had abnonnal tympanic membranes unilaterally while two had 











membrane and abnormal colour) presented as normal but six (which had grommets and 
perforations) had not improved. Table 7 details the nature and frequency of tympanic membranes 
which presented with an abnormal appearance (pre and post medical intervention). 
Table 7 
Nature and Frequency of Tympanic Membranes with Abnormal Appearance (Pre and Post 
Medical Intervention) 
Perforation Grommet Bulging Retraction Abnormal colour 
Pre-intervention 3 3 2 0 2 
Post-intervention 3 3 0 0 0 
Note. Two ears presented with bulging and abnormal colour simultaneously. Two of the ears 
with perforations also presented with otorrhea. 
1.2.2. Function of the middle ear 
1.2.2.1. Impedance and admittance 
Tympanometry was not conducted on six ears as they had grommets in situ or tympanic 
membrane perforations. Tympanometry on the remaining 52 ears (28 participants), prior to 
medical intervention, revealed that 73% (n = 38) of ears had type A tympanograms, indicating 
normal middle ear function, 21 % of ears (n = 11) had type B tympanograms, associated with 
middle ear fluid or micro-perforation of the tympanic membrane, and 6% of ears (n = 3) had type 
C tympanograms associated with Eustachian tube disorders or middle ear fluid. In essence, 36% 
(n = 10) of participants (14 ears) had abnormal tympanograms, with four presenting bilaterally 











(due to the death of one participant and the hospital discharge of the other) the remaining 10 ears 
presented as normal with type A tympanograms post medical intervention. 
1.2.2.2. Ipsilateral acoustic reflexes 
Ipsilateral acoustic reflex examination was not conducted on six ears as they had grommets in 
situ or perforations of the tympanic membrane. The examination on the remaining 52 ears (28 
participants), before medical intervention, revealed that 62% (n = 32) of ears had ipsilateral 
acoustic reflexes and 38% (n = 20) of ears (54% of participants) had no ipsilateral acoustic 
reflexes. Six participants had absent acoustic reflexes bilaterally while eight had unilateral 
presentations. None of the participants were referred to a medical practitioner for the absence of 
acoustic reflexes as further audiologic investigation was required prior to referral. In all ears with 
absent ipsilateral acoustic reflexes (n = 20) a strong association was observed with middle ear 
pathology or facial nerve disorder, indicating that there was no auditory neural involvement or 
idiopathic absence of acoustic reflexes (See Table 8). 
Table 8 
Conditions which may have Contributed to Participants' Absent Ipsilateral Acoustic Reflexes 
Total 
Conditions contributory to the absence 
of an ipsilateral acoustic reflexes 
Type B tympanogram 
Type C tympanogram 
Facial nerve disorder 


























1.2.4. Unresolved middle ear abnormality 
The assessment of the middle ear status in 58 ears revealed that 47% (n = 27) of ears (55% of 
participants) had middle ear abnormality. Of the 27 ears, 18 ears were referred for medical 
attention, 39% (n = 7) of which still had unresolved middle ear problems post medical 
intervention (See Table 9). The results (X = 7.809, df = 1, p = .005) indicated that there were 
significantly fewer ears with middle ear abnormality post medical intervention suggesting 
successful resolution following treatment. Of the remaining nine ears which were not referred to 
a medical practitioner, four ears were lost (two participants were discharged from the hospital or 
died) and five ears had absent ipsilateral acoustic reflexes with normal otoscopic and 
tympanometric examination results and required further audiologic investigations prior to 
medical referral. 
Table 9 
Frequency and Nature of Middle Ear Abnormality of Ears Referred for Medical Intervention 
Middle ear abnormality Pre intervention Post intervention 
{ears) {ears} 
n % n % 
Perforation ofTM 3 17 3 17 
Grommet 3 17 3 17 
Type C tymp & absent Ipsi AR 2 11 1 5 
Type B tymp & absent Ipsi AR 8 44 0 0 
Bulging & red TM 2 11 0 0 
Total 18 100 7 39 











Summary of the Prevalence of the Outer and Middle ear Abnormalities Before and After 
Medical Intervention 
Table 10 reflects the outer and middle ear status in three different age groups (pre and post 
medical intervention). The outer ear of 14% of the participants had impacted cerumen which was 
removed following referral to a medical practitioner. The middle ear function in 55% (n = 16) of 
the participants was abnormal, of whom 75% (n = 12) were referred for medical intervention and 
the rest for further audiological evaluation (except two participants who were discharged from 
the hospital or died). Fifty percent (n = 6) of participants still had unresolved middle ear 
dysfunction following medical intervention. 
Table 10 
Outer and Middle Ear Status in Three Different Age Groups (pre and post medical intervention) 
Age Group (in years) 
Assessment Status I II III 
(::s 3 yr) (>3&9yr) (>7 &<18 yr) 
N=18 N=12 N=28 
n % n % n % 
Otoscopic Normal 16 89 11 92 24 86 
examination Impacted wax 2 11 1 8 4 14 
of outer ear Structural abnormality 0 0 0 0 0 0 
= Foreign objects 0 0 0 0 0 0 0 
.~ Growths 0 0 0 0 0 0 
t Infection 0 0 0 0 0 0 
.S Normal 12 67 12 100 24 86 
ta Otoscopic Abnormal colour 2 11 0 0 0 0 0 .- examination as Perforated 0 0 0 0 3 11 
8 (TM) Grommet 2 11 0 0 1 4 
J: Bulging 2 11 0 0 0 0 
Retraction 0 0 0 0 0 0 
Tympanometric Type A 7 39 11 92 20 71 











TypeC 2 11 0 0 1 4 
CNT 2 11 0 0 4 14 
Ipsilateral AR Present 5 28 11 92 14 50 
examination Absent 11 61 1 8 10 36 
CNT 2 11 0 0 4 14 
Otoscopic Normal 18 100 12 100 28 100 
examination Impacted wax 0 0 0 0 0 0 
of outer ear Structural abnormality 0 0 0 0 0 0 
Foreign objects 0 0 0 0 0 0 
= Growths 0 0 0 0 0 0 0 Infection 0 0 0 0 0 0 .-
5 Otoscopic Normal 16 89 12 100 24 86 
i examination Abnormal colour 0 0 0 0 0 0 .- (TM) Perforated 0 0 0 0 3 11 
ta Grommet 2 11 0 0 1 4 u 
~ Bulging 0 0 0 0 0 0 e Retraction 0 0 0 0 0 0 t5 
0 Tympanometric Type A 12 67 12 100 24 86 ~ 
examination TypeB 0 0 0 0 0 0 
TypeC 0 0 0 0 0 0 
CNT 2 11 0 0 4 14 
Died or discharged 4 22 0 0 0 0 
Note. Tympanometric and acoustic reflex examination of ears with grommet or tympanic 
membrane perforation was not done. None of the participants were referred to a medical 
practitioner for the absence of acoustic reflexes as further audiologic investigation was required 
prior to referral. yr= year. CNT= could not test. N = total number of ears. 
2.1. Prevalence of hearing loss 
The evaluation of hearing status was only possible in 50 of the 58 ears (one participant died, two 
participants were discharged and one participant who was under 3 years of age had grommets in 
both ears). Of 50 ears, in which hearing status was evaluated, 34% (n = 17) of ears [48% of 
participants (n = 12)] had hearing loss (threshold greater than 15 dB HL in at least one frequency 

















Pure tone audiometry 
2.2. Nature of the hearing loss 










The type, configuration, degree, laterality and symmetry of the hearing loss are described in 
detail. 
2.2.1. Type and configuration of the hearing loss 
Of 12 participants with hearing loss, 75% (n = 11) had sensorineural hearing loss (with 65% of 
ears affected), while 25% (n = 6) of hearing impaired participants presented with mixed hearing 
loss (with 35% of ears affected). In 25% (n = 6) of the hearing impaired participants the 
configuration of hearing loss was flat (with 35% of ears affected) and in 75% (n = 11) it was 
high frequency loss (with 65% of ears affected). 
2.2.2. Degree 
The results for the degree of hearing loss were influenced by the classification system utilized. 
When the Northern and Downs (2002) classification system (based on pure tone averages of 0.5, 
1 & 2 kHz) was used, 41 % of hearing impaired participants (16% of ears) had mild to profound 
c 











participants (59%) was within the nonnal range]. However, when the average of the thresholds 
for the high frequencies of 4, 6 and 8 kHz (instead of the average at 0.5, 1 and 2 kHz) were 
calculated there was an increase to 66% of hearing impaired participants (28% of ears) with mild 
to profound hearing loss. See Table 12 for the comparison of the degree of hearing loss between 
conventional pure tone average and high frequencies pure tone average. 
Table 12 
Degree of Hearing Loss Based on the Conventional PTA and High Frequencies PTA 
Conventional PTA High frequencies PTA 
(0.5, 1 & 2 kHz) (4,6&8kHz) 
n % n % 
Nonnal (0-15 dB HL) 42 84 36 72 
Degree of 
Mild (15-30 dB HL) 5 10 6 12 Hearing Loss 
Moderate (30-50 dB HL) 0 0 4 8 
Severe (50-70 dB HL) 1 2 2 4 
Profound {70+ dB HL} 2 4 2 4 
Total (ears with mild to profound HL) 8 16 14 28 
Note. PTA= pure tone average. HL= hearing loss. n= number of ears. 
2.2.3. Laterality and symmetry 
Of the 12 participants (17 ears) with hearing loss, 58% (n = 7) presented unilaterally and 42% (n 
= 5) bilaterally. In the five participants with bilateral hearing loss, 80% (n = 4) of the losses were 
symmetrical while 20% (n = 1) were asymmetrical. 











Table 13 reflects the frequency and nature of hearing loss in the two older age groups (there was 
no hearing loss in the youngest age group). Forty eight percent of the participants (34% of ears) 
presented with hearing loss, of which 75% had sensorineural hearing loss while 25% had mixed 
hearing loss. The degree of hearing loss varied depending on which classification system was 
utilized. When Northern and Downs (2002) classification system was used, of 12 hearing 
impaired participants, 41 % had mild to profound hearing loss. However, when the average of 
the thresholds for the high frequencies of 4, 6 and 8 kHz were calculated (using the same 
classification system), of 12 hearing impaired participants, 66% had mild to profound hearing 
loss. Thus using the high frequency pure tone average increases the number of participants 
whose degree of hearing loss is outside the normal range. 
Table 13 
The Frequency and Nature of Hearing Loss in the Two Older Age Groups 
Age group 
II III 
Hearing status (> 3 yr & ~ 7 yr) (> 7 yr & < 18 yr) 
(of ears) N=lO N=24 
n % n % 
Normal hearing 8 80 9 37 
Hearing loss 2 20 15 62 
SNHL 2 100 9 60 
TypeofHL MixedHL 0 0 6 40 
Conductive HL 0 0 0 0 
High frequency loss 2 100 9 60 
Configuration Flat 0 0 6 40 
ofHL Low fre9.uenc~ loss 0 0 0 0 
Normal (0-15 dB HL) 9 90 17 71 
(Average: Mild (15-30 dB HL) 1 10 4 17 
0.5,1 & 2 Moderate (30-50 dB HL) 0 0 0 0 
kHz) Severe (50-70 dB HL) 0 0 1 4 
Degree Profound (70+ dB HL) 0 0 2 8 
ofHL Normal (0-15 dB HL) 9 90 11 46 













Moderate (30-50 dB HL) o o 4 17 
Severe (50-70 dB HL) 0 0 2 8 
Profound (70+ dB HL) 0 0 2 8 
Note. There was no hearing loss in the age group I (aged 0 to 3 years); N= total number of ears. 
HL= hearing loss; SNHL= sensorineural hearing loss. 
3.1. Determination of the relationship between middle ear abnormality and sex 
There were 26 ears in the male group and 32 ears in the female group. Fifty four percent of ears 
(n = 14) in the male group had middle ear abnormality compared to 41 % of ears (n = 13) in the 
female group with middle ear abnormality. The frequency of ears with middle ear abnormality in 
male and female groups was not significantly different eX! = .575, df= l,p = .448). 
3.2. Determination of the relationship between middle ear abnormality and age 
Seventy two percent of ears (n = 13) in age group 0 to 3 years, 8% of ears (n = 1) in age group 3 
to 7 years and 46% of ears (n = 13) in age group 7 to 18 years had middle ear abnormality. See 
Table 10 for more details. The frequency of middle ear abnormality was significantly less (Jf = 
6.620, df= 2,p = .038) in group 3 to 7 years than in groups 0 to 3 years and 7 to 18 years. 
3.3. Determination of the relationship between middle ear abnormality and duration of 
hospitalization 
Sixty six percent of ears (n = 38) belonged to participants who were hospitalized for less than six 
months (group A) and 34% of ears (n = 20) belonged to participants who were hospitalized for 
more than six months (group B). Forty seven percent of ears (n = 18) in group A had middle ear 











frequency of middle ear abnormality in these two groups was not significantly different 
(Generalized Linear Models, Jf = .096, df= l,p = .757). 
3.4. Determination of the relationship between duration of ototoxic drug exposure and 
sensorineural hearing loss 
Children admitted to Brooklyn Hospital had previously received TB medication at a referral 
center, the nature of which could not be determined from the medical records. It was therefore 
not possible to rule out the use of ototoxic medication prior to hopitalization at Brooklyn Chest 
Hospital. Thus, the duration of ototoxic drug exposure was unknown and its relationship with 
sensorineural hearing loss could not be determined. 
3.5. Determination of the relationship between type of ototoxic drugs and sensorineural 
hearing loss 
The ototoxic TB drugs used at Brooklyn Chest Hospital are amikacin, capreomycin and 
streptomycin. Since 86% of the current study's participants received amikacin and the remaining 
14% were on capreomycin or streptomycin, the relationship between type of ototoxic drug and 
sensorineural hearing loss could not be analysed statistically. 
3.6. Determination the relationship between type of TB and sensorineural hearing loss! 
middle ear abnormality 
In the present study the prevalence of pulmonary TB, TB meningitis, disseminated TB and TB of 











TB with the remaining minority having other forms of TB, the relationship between type of TB 
and sensorineural hearing loss/middle ear abnormality could not be analysed statistically. 
3.7. Determination of the relationship between middle ear abnormality and comorbid 
presentation of mv and TB 
Of 29 participants, 18 participants (36 ears) had TB while 11 participants (22 ears) had both TB 
and HIV. In the TB group 39% of ears (n =14) had middle ear abnormality as compared to 57% 
of ears (n =13) in the TB and HIV group. The frequency of middle ear abnormality in these two 
groups was not significantly different (X = 1.267, df= 1,p = .260). 
3.8. Determination of the relationship between sensorineural hearing loss and comorbid 
presentation of mv and TB 
Of 25 participants (which their hearing status were known), 16 participants (32 ears) had TB 
whil~ nine participants (18 ears) had both HIV and TB. In the TB group 25% of ears (n = 8) had 
sensorineural (or mixed) hearing loss while in the TB and HIV group 50% of ears (n = 9) had 
sensorineural (or mixed) hearing loss. The frequency of the ears with sensorineural (or mixed) 
hearing loss in these two groups was not significantly different (X = 3.351, df= 1,p = .067). 
Auditory Function of Participants with TB who are Receiving Ototoxic Drugs 
In the present study 55% of the participants had middle ear abnormality and 48% had some 
degree of hearing loss. Forty two percent of hearing impaired participants demonstrated 
moderate to profound hearing loss in high frequencies (4, 6 & 8 kHz), which are typically 












The results of the present study will be discussed in light of the current literature and the 
implications for clinical practice and future areas of research will be considered. Firstly, the 
prevalence and nature of outer and middle ear abnormalities will be discussed. Then, the 
prevalence and nature of the hearing loss will be discussed. Lastly, the relationship between 
sensorineural hearing loss/middle ear abnormality and other parameters will be discussed 
Prevalence of Outer and Middle Ear Abnormalities 
The prevalence rate of impacted wax in participants, who were hospitalized for TB at Brooklyn 
Chest Hospital, was 14%. Impacted wax is generally a silent condition and can cause tinnitus, 
vertigo, itching, pain, infection and sometimes hearing loss (Subha & Raman, 2006). The 
configuration of the hearing loss is nearly flat and the degree varies between 30 and 40 dB 
(Stach, 2008). In the current study the presence of impacted cerumen was not restricted to any 
particular age group and its effect on hearing was unknown since the hearing status of 
participants was determined after removal of the impacted wax. Many studies have addressed the 
prevalence rate of impacted wax among school children within the last decade, with only few 
studies in this decade. Minja and Machemba (1996) reported a similar prevalence rate (15.7%) of 
impacted ear wax among school children in Tanzania, while Phaneendra and Rao et al., 2002; 
and Adhikari, 2009 reported much higher prevalence rates of 63% and 62% in rural school 
children in India and Nepal respectively. Both of these studies had a much larger sample size 
(N=855 and N=2000) and a limited age range (5-6 years and 5-13 years) when compared with 
the current study's cohort of 29 children whose ages ranged between 0 and 18 years. The current 











a study of school children (7 to 10 years) in Bosnia and Herzegovina. The reason for the lower 
prevalence rate in the present study cannot be determined. 
Although the hearing loss associated with impacted cerumen is often mild, it can have a 
significant impact on school-aged children as well as younger children who are in the process of 
developing speech and language (Stach, 2008; Northern & Downs, 2002). Thus screening for the 
presence of impacted wax in children hospitalized for TB with subsequent referral for cerumen 
management may prevent conductive hearing loss and its negative consequences in this 
population (Subha & Raman, 2006). 
The prevalence rate of middle ear abnormality in participants, who were hospitalized for 
TB at Brooklyn Chest Hospital, was 55%. Middle ear abnormality causes mild or moderate 
conductive hearing loss up to 60 dB HL (Bluestone & Klein, 2007). Sensorineural hearing loss 
can also result from an untreated middle ear abnormality or its complications (Bluestone & 
Klein, 2007). In the present study, the effect of middle ear abnormality on hearing could not be 
determined since the hearing status of participants was assessed following medical referral for 
middle ear problems. The high prevalence of middle ear abnormality (55%) in this study could 
be explained by the fact that it was conducted during winter, when the prevalence of ear 
infections has been reported to be much higher (Okur et al., 2004). Moreover, the participants in 
this study were immunocompromised children living in close quarters with lots of other sick 
children, which could have contributed to the high prevalence of middle ear infection (Cober & 
Johnson, 2005). 
Comparisons of the current study's results with others on a similar topic cannot be easily 











abnormality of the tympanic membrane or middle ear), while others have reported on the 
abnormalities of middle ear and tympanic membrane separately. In order to compare the result of 
the present study with others, the numbers of the tympanic membrane and middle ear 
abnormalities were added together wherever possible (when the same child did not present with 
more than one pathology). 
The prevalence of middle ear abnormality in the present study (55%) is similar to the 
combined prevalence rate of 53% reported for Aboriginal school-aged children in Australia by 
Sockalingham et al. (2003). It also closely approximates the combined prevalence rate of 49% 
reported by Olusanya et al. (2000), in eight randomly selected schools in Nigeria. 
Adhikari (2009) found that 15% (combined prevalence rate of middle ear and tympanic 
membrane abnormalities) of rural school children in Nepal had middle ear abnormality. The low 
prevalence rate of middle ear abnormality in Adhikari's study when compared with the current 
study could be due to the high prevalence of unremoved impacted wax (62%) in that study, 
which rendered the assessment of middle ear status impossible. Thus the figure 15% is not a true 
reflection of the percentage of children with middle ear abnormality in Adhikari's study. 
Middle ear abnormality may lead to conductive and sensorineural hearing loss which can 
adversely affect the development of speech, language, and cognitive skills in children (Bluestone 
& Klein, 2007; Northern & Downs, 2002). In the present study more than half of the participants 
including older children had middle ear abnormality; therefore it is important to monitor the 
middle ear status of all children hospitalized for TB to prevent hearing loss and its negative 
consequences in this vulnerable group. 











In the present study, 48% of the participants who were exposed to ototoxic drugs had hearing 
loss (threshold> 15 dB HL), 41 % of which had mild to profound hearing loss with the remaining 
(59%) within the normal range (in 59% of hearing impaired participants the hearing loss was 
restricted to high frequencies and undetected by Northern and Downs classification system). The 
type of hearing loss was sensorineural (75%) or mixed (25%) and its configuration was high 
frequency (75%) or flat (25%). As no baseline audiograms/OAE results were obtained prior to 
the treatment with ototoxic drugs, the hearing loss cannot be reliably attributed to these drugs. 
Thus, the term "prevalence rate of sensorineural hearing loss" and not "prevalence rate of 
ototoxic hearing loss" has been used to describe the percentage of children with hearing loss 
following administration of ototoxic drugs. 
Comparisons of the reported prevalence rates in the literature and the prevalence rate in 
this study pose a challenge due to differing methodologies, including ages of the participants, 
hearing loss criteria and the sample size. Following an extensive search of the literature, using 
Google Scholar and Pubmed search engines, there were no other documented studies which 
assessed the effects of ototoxic medication on the hearing of children with TB; studies which 
investigated the ototoxicity were conducted on adults, thus limited inferences can be drawn from 
them about the impact of these drugs on children's hearing. Moreover, the hearing loss criteria 
that were used in this study were different from the studies on adults in two ways. First, in the 
current study the hearing loss criteria was set at 15 dB HL at anyone test frequency (Northern & 
Downs, 2002) while in studies which had baseline audio grams, 10 to 20 dB loss from the 
') 
baseline was considered as hearing loss (peloquin et al., 2004; de Jager & van Altena 2002; 
Sturdy et al., 2011; Duggal & Sarkar, 2007). Second, the frequency range of the audiograms in 











kHz). The current study's sample size (N = 25) is smaller than the sample size in other studies, 
which ranged from 36 to 110 participants (Peloquin et al., 2004; de Jager & van Altena 2002; 
Sturdy et al., 2011; Duggal & Sarkar, 2007; Lima et aI., 2006). Despite these differences, 
comparisons may be made with caution and the results of studies done in adults are compared 
with results of the current study. 
The prevalence of sensorineural hearing loss is variable, ranging from18% to 64%, 
depending on the methods used and the population characteristics (Peloquin et al., 2004; de Jager 
& van Altena 2002; Sturdyet al., 2011; Duggal & Sarkar, 2007; Lima et al., 2006). In the present 
study, the prevalence of sensorineural hearing loss in children who received amikacin, 
streptomycin or capreomycin was 48%. This prevalence rate (48%) is lower than the prevalence 
rate of 64% reported by Lima et al. (2006) in Brazil. A major difference between the two studies 
is that Lima et al. used a Damplex audiometer (model 65), which emitted tone in frequency range 
of 0.25 to 12 kHz , to easier recognize ototoxic alterations at higher frequency, while the current 
study used a MA51- audiometer with frequency range of 0.25 to 8 kHz. 
The current study'S hearing loss rate of 48% is higher than that of other studies conducted 
by Peloquin et al. (2004) in the USA (37%, N=87), de Jager and van Altena (2002) in the 
Netherlands (18%, N=110), Sturdy et al. (2011) in the UK (28%, N=50) and Duggal and Sarkar 
(2007) in the India (18.7%, N=64). Irrespective of the different methods used, children may be at 
greater risk for ototoxicity than similarly treated adult patients (Schell et al., 1989; Kokotas et al., 
2007), which could explain the higher prevalence rate of hearing loss reported in the current 
study. Perhaps, a longer study (from the time of ototoxic drug exposure until 6 months post 
treatment) with a larger sample size may help to determine the vulnerability for ototoxicity in 











Tourn et al. (2005) assessed disequilibrium and tinnitus in addition to hearing loss in 
adults in Turkey and reported an ototoxicity prevalence rate of 42%. The vestibulotoxicity and 
tinnitus were not investigated in the current study (and in no other studies on children with TB) 
but they need to be addressed in future studies and audiologists need to be aware of the fact that 
vestibulotoxicity and tinnitus may be complications of ototoxic treatment (Rybak et al., 2006; 
Tourn et al., 2005) in children. 
The present study suggests that a high percentage (48%) of the participants may have 
ototoxicity. It is also possible that there were participants whose hearing thresholds deteriorated 
following ototoxic treatment but remained within the normal range. Due to the lack of baseline 
audio grams, the ototoxic effect in these participants was undetected. Moreover, some of the 
participants who passed OAE and AABR tests may have had mild ototoxic hearing loss, since a 
"pass" result means that the hearing thresholds (in tested frequencies) were less than 30 dB HL. 
Nevertheless, the results of the current study indicate that at least half of the participants in this 
study had sensorineural hearing loss, the disabling effect of which depends on various factors; 
particularly its degree, laterality and configuration (Probst, 2006; Knight, 2008). 
In the current study the degree of hearing loss varied between mild to profound. Children 
with mild hearing loss (15-30 dB HL) miss voiceless consonants, short unstressed words and less 
intense speech sounds which may result in lack of attention, and mild speech and language 
delays. With moderate hearing loss (31-50 dB HL) speech sounds are heard inaccurately and 
therefore most of the conversational speech sounds may be missed (Northern & Downs, 2002). 
These children present speech intelligibility and learning problems. Children with severe hearing 
loss (50-70 dB HL) can only hear some very loud sounds and the most intense conversational 











(Northern & Downs, 2002). Children with profound hearing loss (70+ dB HL) generally cannot 
hear sounds, which results in severe language retardation as well as learning problems (Northern 
& Downs, 2002). 
The severity of the effect of the hearing impairment is also related to the laterality of 
hearing loss (Probst, 2006). In the current study, the hearing loss was found to be unilateral in 
58% and bilateral in 42% of the participants with hearing loss. Unilateral hearing loss in 
childhood reduces the auditory stimulation from one ear and may result in speech and language 
delays (Probst, 2006). School children with unilateral hearing loss may also have learning 
problems especially where there is background noise, like a noisy classroom (Probst, 2006; Lieu, 
2004). Bilateral hearing loss (depending on its severity) may lead to articulation problems, 
delays in language acquisition, poorly comprehensible speech and absence of spontaneous 
speech development (Probst, 2006). 
In addition, the effect of hearing impairment in children is influenced by the 
configuration of hearing loss. In high frequency losses (due to otoxicity), the high-pitched 
consonant sounds (s, f, th, sh, h, k, p, t) are lost and thus the ability to perceive the range of 
speech sounds necessary for speech and language development is diminished (Knight, 2008). In 
summary, even mild unilateral or high frequency hearing loss may have a serious disabling effect 
in children (Northern & Downs, 2002; Probst, 2006). Therefore the monitoring of hearing status 
in children with TB receiving ototoxic drugs is recommended, as early detection and intervention 
may prevent further hearing loss or minimize its progression. 
It should be mentioned that the impact of hearing loss in a child who is ill with a 











hospitalization and shortage of health care personnel and facilities in developing countries like 
South Africa divest these children from adequate communication with nurses/parents, interaction 
with their healthy peers, formal schooling and normal socialization which may lead to 
educational challenges, social and emotional problems and linguistic deprivation (Nelson, 2007; 
Ruben, 2003). This issue once again emphasizes the need for ototoxicity monitoring in children 
with TB. 
There is a great chance of developing further sensorineural hearing loss in hearing 
impaired children with TB. Children who have sensorineural hearing loss may be at risk for 
exacerbating the loss through continuous exposure to ototoxic drugs, re-administration of 
ototoxic medications (for recurrent TB or the occurrence of other infections) and noise-induced 
hearing loss (e.g. listening to loud music via earphones). Thus health care providers and 
parents/guardians should be made aware of these issues to avoid progression of sensorineural 
hearing loss in this population. 
The results of the current study suggest that 42% of the hearing impaired participants 
would be eligible for hearing aids. They may benefit from personal FM or sound field FM 
system in the classroom and may require special support for their language development and 
education (Adams & Rohring, 2004). The rest of the hearing impaired participants (58%) with 
mild hearing loss or just slight high frequency losses do not necessarily require hearing aids but 
may need favourable seating in the classroom, counselling and special attention from their 
teachers and parents (Adams & Rohring, 2004). Therefore, appropriate referral of these children 
upon discharge from TB centers and provision of suitable services in accordance with their needs 
at school, community and hospital/clinic levels are necessary to prevent their hearing 











In the current study using Northern and Downs (2002) classification system~ which is 
based on average degree of hearing loss for speech frequencies (0.5~ 1 & 2 kHz)~ 16% of ears 
had mild to profound hearing loss. Since ototoxic hearing loss affects high frequencies first~ the 
Northern and Downs's classification based on the average degree of thresholds in high 
frequencies (4~ 6 & 8 kHz) was used and a higher percentage (28%) of the ears was found to 
have mild to profound hearing loss. The observed difference in results (16% vs 28%) suggests 
that the conventional classification system (N orthem and Downs) may not be applicable for 
patients who receive ototoxic medication (who tend to be more at risk of initially manifesting 
hearing loss in high frequencies)~ as the initial degree of hearing loss in a high percentage of 
these patients will be considered within the nonnal range. Therefore the criteria for detennining 
the degree of ototoxic hearing loss should be revised. It is recommended that the average of 4~ 6 
and 8 kHz (instead of the average at 0.5~ 1 and 2 kHz) be used to determine the degree of hearing 
loss in the N orthem and Downs (2002) classification system. 
Ototoxicity is determined by comparing the baseline results~ which is preferably obtained 
prior to the initiation of treatment with the ototoxic drug~ and the results of subsequent 
monitoring tests (Campbell~ 2004). In the current study~ due to the lack of baseline 
audiograms/OAE results~ it was not possible to determine the prevalence rate of ototoxicity. The 
reason for the absence of baseline audiograms/OAE in the current study is that the participants 
began their ototoxic treatment in referral hospitals (not Brooklyn Chest Hospital) where hearing 
tests are not routinely performed due to lack of equipment and trained personnel. In 201 O~ the 
Department of Heal~ Republic of South Africa~ proposed a new health care service delivery 
model with a shift from the curative to the cost-effective primary health care model at basic 











recently proposed health care service delivery model, it is recommended that auditory 
monitoring of children receiving ototoxic drugs should be implemented at district hospital/clinic 
level from the initiation of treatment to detect hearing loss. It is also recommended that future· 
studies should include a larger sample size and a longer period of observation from the time of 
ototoxic drug exposure to determine the prevalence of ototoxicity in children. 
Otoacoustic emissions test (in infants and young children) and high frequency 
audiometry (in older children and adolescents) have been considered the best methods for early 
detection of ototoxicity (Stavroulaki et al., 2002; Jacob et aI., 2006). One of the limitations of the 
current study was the lack of a high frequency audiometer. In ototoxicity, higher frequencies 
(base of cochlea) are affected first before the lower frequencies (apex of the cochlea) are 
involved, therefore high frequency audiometry is essential for early detection of hearing loss and 
to prevent communication defects in children (> 3 years) receiving ototoxic TB drugs (Duggal & 
Sarkar, 2007). Hence, although high frequency audiometer is expensive and has its own 
limitations e. g. calibration deficulties (Goodman et al., 2009) it is recommended to purchase it 
for ototoxicity monitoring, given the high prevalence of children with TB at risk of ototoxic 
hearing loss in South Africa. 
The clinical implication of this study is that an ototoxic monitoring program should be 
implemented for all children with TB receiving ototoxic medication. Such a program must begin 
prior to commencement of ototoxic medication at the local clinics to obtain baseline data and 
should be continued at least six months post treatment, as ototoxicity may manifest even after 
cessation of drugs (ASHA, 1994). Review of the literature revealed that there is no specific 
protocol for monitoring ototoxicity in children. It is recommended that a standard protocol be 











The following ototoxicity monitoring program is proposed which should be managed by 
an audiologist (but could be performed by an adequately trained health care provider). Baseline 
testing is the first step of this program and needs to be a complete audiologic evaluation, 
including otoscopy, inimittance, audiometry (preferentially high frequency audiometry) or OAE 
and AABR (depended on patient's age). Since middle ear abnormality is common among 
children and may interfere with the results of the hearing tests, immittance evaluation should be 
done prior these tests (Silveira Netto, da Costa, Sleifer & Braga, 2009). Baseline data must be 
obtained prior to ototoxic drug treatment. The next step is basic monitoring evaluation which 
must be done weekly (ASHA, 1994) and includes otoscopy, OAB and AABR (in young children) 
or air-conduction thresholds (in older children). The results of the air-conduction thresholds 
need to be compared with their baseline results to detect threshold shift. The recommended 
criteria by ASHA (1994) for determination of ototoxic threshold shift from baseline is as 
follows: (i) 20 dB or greater decrease at anyone test frequency, (ii) 10 dB or greater decrease at 
any two adjacent frequencies, or (iii) loss of response at three consecutive frequencies where 
responses were previously obtained. 
Children who show any significant increase in their thresholds (according to ASHA's 
criteria, 1994) or fail the OAB or AABR may have middle ear abnormality, so they must be 
assessed by immittance and if applicable bone-conduction. Children with middle ear abnormality 
need to be referred to a medical practitioner (for medical care). Children with normal middle ear 
function may have sensorineural hearing loss and must be retested for their hearing, those who 
fail OAB or AABR again, should be referred to tertiary hospitals (for further diagnostic tests 
including diagnostic ABR and ASSR) and those with a change in threshold must be reported to 











the opportunity to adjust the therapy to be potentially less ototoxic, and the audiologists the 
opportunity to perform appropriate rehabilitation during and after treatment (Stavroulaki et al., 
2002). 
Determination of the Relationship between Sensorineural Hearing Loss/ Middle Ear 
Abnormality and other Parameters 
There is a difference between the objectives of the current study, pertaining to the middle ear 
abnormality, and the issues reported in the literature. In the present study the middle ear 
abnormality and its relationship with other parameters (e.g. sex, age, duration of hospitalization) 
were assessed, while otitis media with effusion in particular, which is the case in the literature 
was not addressed, so comparisons of the results of this study with those reporting on otitis 
media with effusion (OME) were made with caution. 
The current results suggest no sex differences in middle ear abnormalities in boys (44%) 
and girls (41%). These fmdings are supported by Tong (2006). In Turkey, Caylan (2005) 
reported that male children had significantly more otitis media with effusion than females 
(13.8% versus 8.2%) while Martines (2010) in Italy found the opposite (8.6% female versus 
4.6% male). The discrepancies in results of the above mentioned studies indicate the need for 
further research to ascertain if there are any significant differences between genders regarding 
prevalence of middle ear abnormality. The results of the present study indicate that both male 












Assessment of the relationship between middle ear abnormality and age in this study 
revealed that the frequency of middle ear abnormality was significantly lower for the age group 3 
to 7 years (8%) than the younger (0 to 3 years, 72%) and older (7 to 18 years, 46%) age groups 
(p = .038). This unexpected result cannot be easily explained and may be due to the study's 
limited sample size. However, as expected, the frequency of middle ear abnormality in the 
youngest age group (0 to 3 years) was much higher than the oldest age group (7 to 18 years). 
Martines (2010) in Italy found that with increasing age, the prevalence rate of otitis media with 
effusion decreased. Caylan (2005) in Turkey is in agreement with the finding of Martines, since 
he reported that his study groups I «6 years) and II (7-9 years) had significantly higher otitis 
media with effusion prevalence than group III (> 10 years). Zielhuis et at. (1990) in a review 
article on prevalence of otitis media with effusion (key article), came to the conclusion that the 
prevalence rate of this disease has two peaks: one around 2 years of age and the other around the 
age of 5 years. In the current study, the maximum prevalence rate of middle ear abnormality 
(72%) was in the youngest age group (0 to 3 years) and is in agreement with the first peak (2 
years) reported by Zielhuis. Therefore the present study suggests that although children younger 
than 3 years of age are more prone to middle ear problems than older children, children of all age 
groups are in need of appropriate audiological services. 
In this study there was no significant relationship between duration of hospitalization and 
middle ear abnormality (p = .757). This result is unexpected, as children who are hospitalized for 
a longer period of time are more likely to develop middle ear problems since prolonged close 
contact with other potentially sick children, increases the risk of upper respiratory tract infections 
with subsequent development of otitis media (Cober & Johnson 2005). This unpredictable 











had oral antibiotics for intercurrent infections that had an additional effect of treating silent 
middle ear infection. Currently there are no investigations in the literature (using Google Scholar 
and Pubmed search engines) pertaining to the relationship of duration of hospitalization and 
middle ear abnormality/OME among children, therefore, it is recommended that this issue should 
be assessed in future studies. 
One of the prime objectives of this study was to determine the relationship between 
duration of ototoxic drug exposure and the presence of sensorineural hearing loss. Since the 
information on the date of commencement of ototoxic medication at referral hospitals was not 
available, this issue could not be fully investigated. Lima et al. (2006) reported that differences in 
hearing impairment between adult participants who received streptomycin for a period of more 
than two months and those who were treated for shorter periods of time were not significant 
(77.8% versus 72.2%, respectively). Similarly, Sturdyet a1. (2011) and de Jager and van Altena 
(2002) concluded that the total duration of aminoglycoside treatment was not significantly 
associated with the development of sensorineural hearing loss. Conversely, Peloquin et al. (2004) 
reported that the duration of ototoxic treatment was associated with hearing loss, and in a more 
recent review article in 2010, Arbex et al. concluded that the risk of sensorineural hearing loss 
increased with prolonged duration of treatment. These conflicting results warrant further research 
to ascertain the exact relationship between the duration of drug exposure and the presence of 
sensorineural hearing loss especially in children. 
One of the objective's of the present study was to determine the relationship between the 
type of ototoxic drugs and the presence of sensorineural hearing loss, however, since 86% of the 











or streptomycin, statistical analysis of this objective was not feasible. Peloquin et al. (2004) 
investigated this issue in their study and reported that streptomycin (in adults) was the least 
ototoxic drug when compared to amikacin in terms of cochleotoxicity. Rybak and Ramkumart 
(2007) confirmed Peloquin's findings by suggesting that streptomycin produces predominantly 
vestibular damage, while kanamycin and amikacin mainly affect the cochlea. Sturdy et al. (2011) 
found that amikacin use was significantly associated with ototoxicity and suggested that 
capreomycin might be associated with less ototoxicity when compared with amikacin. 
Kanamycin and amikacin are structurally very similar drugs (Kamal et al., 2008). The above 
mentioned studies suggest that capreomycin may be a safer alternative to amikacin and other 
ototoxic drugs in terms of cochleotoxicity. Future large scale studies including a range of 
ototoxic drugs, in particular, amikacin and capreomycin, will have to determine the least ototoxic 
drug of choice in children. 
In this study the relationship between type of TB and sensorineural hearing loss/ middle 
ear abnormality could not be investigated, since most of the participants had pulmonary TB with 
the remaining minority having other forms of TB. An extensive search of the literature, using 
Google Scholar and Pubmed search, revealed that no study has investigated this issue. Perhaps 
future large scale studies including children with different forms of TB may be able to determine 
if there is any significant association between the type of TB and sensorineural hearing 
loss/middle ear abnormality. 
The present study found no significant relationship between middle ear abnormality and 
comorbid presentation of HN and TB (p = .260). This finding may be explained by the fact that 











such as ear infections. Following a search of the literature, using Google Scholar and Pubmed 
search engines, no other investigations exist on the relationship between middle ear abnormality 
and comorbid presentation of HN and TB. 
There was no significant relationship between sensorineural hearing loss and comorbid 
presentation of HN and TB, in this study (p = .067). The use of Google Scholar and Pubmed 
search engines revealed that no study has ever investigated the relationship between 
sensorineural hearing loss and comorbid presentation of HN and TB in the literature. Future 
studies on duly infected HN and TB children may help determine if sensorineural hearing loss is 
more common in this population. 
In conclusion, there were high prevalence rates of middle ear abnormality (55%) and 
sensorineural/mixed hearing loss (48%) among TB participants receiving ototoxic medication at 
Brooklyn Chest Hospital. The observed prevalence rates reflect that a great percentage of TB 
children receiving ototoxic medication present with hearing loss. The hearing of these children is 
often not assessed at TB centers and their parents are most likely unaware of the possibility of 
ototoxic hearing loss. When hearing impaired children are discharged from medical centers they 
will be faced with life requirements like formal schooling and daily communications. However, 
because of their undetected hearing loss, they may face various problems in areas of speech and 
language learning, educational achievement; social/emotional development with subsequent 
disablement, costing the state sums of money (Copley & Friderichs, 2010; Northern & Downs, 
2002). Thus, implementation of an ototoxicity monitoring program in all TB centers 











ototoxicity, which is the prerequisite for prevention of further hearing loss and providing service 












Despite the high risk of hearing loss in children with TB exposed to ototoxic drugs, their hearing 
is not routinely monitored. The current study's attempt was to describe the auditory function of 
children with TB receiving ototoxic medication at Brooklyn Chest Hospital. An assessment of 
auditory function of these children revealed that, 55% presented with middle ear abnormality and 
48% with hearing loss. The degree of hearing loss in 41 % of the hearing impaired participants 
was mild to profound and in 59%, with their loss restricted to high frequencies, was within the 
normal range. 
The results of the current study indicate that (1) a routine ototoxic monitoring program should be 
implemented for all children with MDR-TB from the time of ototoxic drug exposure until 6 
months post treatment, at district hospital/clinic level. (2) Appropriate services should be 
provided for hearing impaired children in terms of their need for hearing aids, FM systems and 
language and educational support at hospital/clinic, school and community levels. (3) The 
Northern and Downs' degree of hearing loss classification system, based on average thresholds 
for speech frequencies, is not applicable for ototoxic hearing loss, which initially occurs at high 
frequencies. It is therefore recommended that in children at risk of ototoxic hearing loss, the 
average of 4 and 8 kHz (instead of the average at 0.5, 1 and 2 kHz) be used to determine the 
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An Outline of the Information Shared with the Children who were Old Enough to Participate in 
the Decision Making 
Why we would like to speak with you? 
We want to talk with you about being a part of something called a research study. A research 
study is when doctors collect information to learn more about a disease. Doctors who do research 
are also called researchers. 
If you have any questions during our talk about this study, you can ask them. Don't worry about 
waiting until the person talking stops speaking to you. You can stop them at any time and ask 
your question. 
We are doing this research study to learn more about the hearing of children with TB, who are 
taking medication. After we tell you about this research study, we will ask you if you'd like to be 
in this research study or not. If you decide to be in this research study, you will be asked to sign 
this paper. If you don't want to be in this research study, no one will be upset with you. If you 
don't want to be in this research study, just tell us. If you want to be in the research study, tell us 
that. And, remember, you can say yes now and change your mind later. It's up to you. 
This research study is not about getting treatment. You will have treatment for your illness, 
whether or not you agree to be part of this research study. 











TB is the disease you have. When you take medication for TB~ you may be at risk of hearing 
loss. In this research study~ we will try to find out if you have hearing difficulties. If you have 
hearing difficulties~ you will be asked to do extra tests and receive treatment for your hearing 
problem. In this research study~ there will be about 50 children who have TB. 
What will happen to you if you are in the research study? 
If you agree to be in the research study~ this is what you will be asked to do: 
(J) Your outer ear will be examined to make sure that there is nothing in your ear and the 
eardrum is normal. 
(2) Your middle ear will be tested~ to see how well it is functioning. A probe will be placed in 
your ear and you will be asked to be quite. If you have middle ear problem~ you will be 
referred to a doctor. 
(3) Your inner ear and hearing nerve function will be tested by placing headphones on your ear. 
You will be asked to indicate~ when you hear the tones. 
(4) If you have inner ear problem you will be referred for extra tests. 
Will it hurt? 
No~ it won~t. The tests are not painful. 
Will I get paid? 











Your parent/ guardian knows about this study and wants you to be in the study if you want to. If 
you sign below it indicates that you do want to be in the study, but you know that you can stop 
being in the study any time you want to. You know that your study doctor can talk about the 
study with your parent/guardian, but will not talk about it with anyone else who is not working 
on the study unless you and your parent/guardian say it is OK. You can call the study doctor any 
time you have any questions. 
Signature of Child 
Date 












Informed Consent Forms in English 
Informed consent form for parents of participants under 3 years of age 
Dear Parent/Legal Guardian 
I am Nazanin Ghafari a postgraduate student in Audiology at the University of Cape Town. I am 
conducting research on hearing of children receiving TB medication. For the purpose of this 
study I need to access your child's medical records to obtain medical history and other relevant 
information. This study has been given ethical approval by the Research Ethics Committee 
(REC) of the Facu1ty of Health Sciences, University of Cape Town. (REC Reference Number: 
010/2010). 
Purpose of the study: 
Children sometimes may receive TB medication that places them at risk for developing a hearing 
loss. The purpose is to identify whether children who have TB and who receive TB drugs have 
hearing difficu1ties. The earlier a hearing loss is detected the better for the child. If the child is 
found to have a hearing loss, he/she can be referred for further assessments/management (of their 
hearing) and can be given early therapy. The child will then have the best chance of continuing 
to develop his/her language and communication skills. It also alerts the doctors, so that they can 












What does taking part in the study mean? 
The researcher will first examine the outer ear of your child. It is important to look in the child's 
ear, in order to make sure that there is nothing in the ear and that the eardrum is normal. Your 
child's middle ear will be tested to see how well it is functioning. During this test 
(Tympanometry & Acoustic Reflex) a probe will be placed in your child's ears. If your child has 
a middle ear problem, he/she will be referred to a doctor at Brooklyn Chest Hospital. 
Your child's inner ear will be tested by putting a probe fitted with a soft tip in the ear canal (This 
procedure is similar to the one nurses/doctors use to measure your child's temperature from the 
ear). The probe produces a sound and has a microphone which will record the response of your 
child's inner ear. The other end of the probe is connected to the screening machine which will 
tell us whether your child's inner ear is normal or whether we need to refer your child to 
audiology services. Your child may be sleep or awake while this test is being done. The 
researcher will then test the function of your child's hearing nerve. For this test (Automated 
Auditory Brainstem Responses), I will use a cotton swab to clean the skin of your child's scalp, 
forehead and one earlobe. Thereafter I will place some paste on the skin in these areas and attach 
electrodes. An electrode has a tiny disc at one end which will pick up the signals produced by 
your child's hearing nerve in response to a click sound. The electrodes are connected to a 
computer so that the results can be analyzed. 
If your child does not pass the inner ear and hearing nerve tests, shelhe will be referred to Red 
Cross Hospital for further diagnostic tests (Auditory Brainstem Responses & Auditory Steady-
State Responses) to determine the level at which your child can hear. This procedure will be 











For this purpose, four small stickers will be placed on your child's head and these will be 
connected to the computer. Earphone will then be placed on your child's ears. Sounds will be 
presented through the earphone to each ear separately while the computer records the results. 
Your child should be sleeping for the duration of the test. If your child is under the age of six 
months, he/she will not be sedated, and the test is performed while he/she is naturally sleeping, 
following a feeding. If your child is over the age of six months, he/she will be examined by the 
doctor who will check that your child is well enough to receive medication - to make your child 
sleep during the test. If your child is well enough, the doctor will give herlhim the medication. 
The reason that your child needs to be asleep for the test is that shelhe needs to remain very still 
and quiet during the test, and this is difficult for small children. The audiologist at the hospital 
will conduct the hearing test on your child, while shelhe is sleeping. The hearing test does not 
cause any harm or injury and is done routinely at the hospital for all small children who need 
such tests. A nurse will remain with your child throughout the test and will make sure that your 
child is fully awake before she/he is discharged. The researcher will access the results once the 
test has been performed. 
For these tests, your child will be seated or rest comfortably, we will only carry out the tests once 
your child has agreed to the tests. The tests will take approximately 30 to 40 minutes depending 
on hearing status of the child. For children referred to Red Cross Hospital for further diagnostic 
tests, the tests will take about 2 hours. 
Risk and Discomfort: 











• All tests are non-invasive and are not painful to your child. 
• Children referred to Red Cross Hospital for additional audiometric examinations under 
sedation; there are some side effects of the medication that may occur, but these are very 
unusual. Sometimes the medicine may make your child restless before they fall asleep. 
In children who are obese i.e. very fat, or who have problems with their nervous system, 
there is a slightly increased risk that the medication could induce a coma and even death. 
We do wish you to become alarmed by this information. This is a very rare event and has 
not occurred in the Cape Town area in the last 20 years. A medical professional (doctor 
or nurse) is routinely responsible for managing the medication and the test is conducted at 
a hospital, which has all the equipment to help your child should the need arise. You will 
be informed of the date and time of the appointment and we would like to encourage you, 
if at all possible, to be with your child. Please do not be alarmed. While this sounds very 
worrying, it is a routine test done regularly at this hospital and around the world, to test 
the hearing of very small children. 
Benefits: 
If your child has a hearing loss we will be able to identify it early and refer herlhim for further 
tests or examination by an ear, nose and throat doctor. If the doctor is alerted to the effect of 
medication on your child's hearing, he/she may be able to change the medication and in this way 
your child is protected from further drug related hearing loss. Your child will receive stickers or 
a pen for participating in the study. The results of the study may also contribute to a range of 













Participation in this study is voluntary. If you decide that you do not want your child to 
participate in this study, your child will continue to receive standard care without prejudice or 
penalty. If you agree to let your child participate but later decide to discontinue the hearing tests 
you are welcome to do so at any time. 
I would like to encourage you to have your child's hearing assessed so that he/she can get the 
necessary care that is required. If you wish, the resident audiologist at Brooklyn Chest Hospital 
can assess your child's hearing. If you decide not to have your child's hearing tested, we would 
like to advise you to pay careful attention to whether your child responds to sounds around 
him/her, especially whether shelhe pays attention when you talk to him/her. It is important for 
your child to hear people talking, so that shelhe can continue to learn communication skills. If 
you become concerned about your child's hearing at any time in the future, please go to Red 
Cross Children's hospital or Tygerberg Hospital for hearing tests. 
Confidentiality: 
All information collected during your child's stay at Brooklyn Chest Hospital and after discharge 
will be handled with confidentiality. Your child's hospital records and the results of the tests will 
be handled with caution, and will not be shown to anyone other than the healthcare professionals 












For any further information please feel free to contact me and my supervisors. My name is 
Nazanin Ghafari, my contact number is 0788335350 and my email address is 
nazanin_gh59@yahoo.com. 
My supervisors are: 
1. Prof Shajila Singh 
Phone: 021-4066041; email: Shajila.Singh@uct.ac.za 
2. Lucretia Petersen 
Phone: 021-4066993; email: Lucretia.Petersen@uct.ac.za 
3. Mrs Christine Rogers 
Phone: 021-4066315; email: Christine.Rogers@uct.ac.za 
Chairperson of the Research Ethics Committee, Prof Marc Blockman 
Phone: 021-4066496 











Informed consent form for parents of participants older than 3 years of age 
Dear ParentJLegal Guardian 
I am Nazanin Ghafari a postgraduate student in Audiology at the University of Cape Town. I am 
conducting research on the hearing of children receiving TB medication. For the purpose of this 
study I need to access your child's medical records to obtain medical history and other relevant 
information. This study has been given ethical approval by the Research Ethics Committee 
(REC) of the Faculty of Health Sciences, University of Cape Town. (REC Reference Number: 
010/2010). 
Purpose of the study: 
Children sometimes may receive TB medication that places them at risk for developing a hearing 
loss. The purpose is to identify whether children who have TB and who receive TB drugs have 
hearing difficulties. The earlier a hearing loss is detected the better for the child. If the child is 
found to have a hearing loss, he/she can be referred for further assessments/management (of their 
hearing) and can be given early therapy. The child will then have the best chance of continuing 
to develop hislher language and communication skills. It also alerts the doctors, so that they can 
consider alternative medicines for your child, medicines that may not be harmful to your child's 
hearing. 
What does taking part in the study mean? 
The researcher will first examine the outer ear of your child. It is important to look in the child's 











child's middle ear will be tested to see how well it is functioning. During this test 
(Tympanometry & Acoustic Reflex) a probe will be placed in your child's ears. If your child has 
a middle ear problem, he/she will be referred to a doctor at Brooklyn Chest Hospital. 
Your child's inner ear and auditory nerve function will be assessed by placing headphones on 
your child's ears. She/he will be asked to indicate when she/he hears the tones. 
If your child has an inner ear or auditory nerve problem, he/she will be referred to audiology 
services for further diagnostic assessments. 
For these tests, your child will be seated comfortably; we will only carry out the test once your 
child has agreed to the tests. The tests will take approximately 30 to 45 minutes depending on 
hearing status of the child. 
Risk and Discomfort: 
• These tests are used routinely in hearing assessments of children. 
• There are no risks for your child, all tests are non-invasive and are not painful to your 
child. 
Benefits: 
If your child has a hearing loss we will be able to identify it early and refer herlhim for further 
tests or examination by an ear, nose and throat doctor. If the doctor is alerted to the effect of 
medication on your child's hearing, he/she may be able to change the medication and in this way 
your child is protected from further drug related hearing loss. Your child will receive stickers or 











services being provided to children with TB, who receive medications that may affect their 
hearing. 
Voluntary Participation: 
Participation in this study is voluntary. If you decide that you do not want your child to 
participate in this study, your child will continue to receive standard care without prejudice or 
penalty. If you agree to let your child participate but later decide to discontinue the hearing tests 
you are welcome to do so at any time. 
I would like to encourage you to have your child's hearing assessed so that he/she can get the 
necessary care that is required. If you wish, the resident audiologist at Brooklyn Chest Hospital 
can assess your child's hearing. If you decide not to have your child's hearing tested, we would 
like to advise you to pay careful attention to whether your child responds to sounds around 
him/her, especially whether shelhe pays attention when you talk to him/her. It is important for 
your child to hear people talking, so that shelhe can continue to learn communication skills. If 
you become concerned about your child's hearing at any time in the future, please go to Red 
Cross Children's hospital or Tygerberg Hospital for hearing tests. 
Confidentiality: 
All infonnation collected during your child's stay at Brooklyn Chest Hospital and after discharge 
will be handled with confidentiality. Your child's hospital records and the results of the tests will 
be handled with caution, and will not be shown to anyone other than the healthcare professionals 












For any further infonnation please feel free to contact me and my supervisors. My name is 
Nazanin Ghafari, my contact number is 0788335350 and my email address is 
nazanin _gh59@yahoo.com. 
My supervisors are: 
1. Prof Shajila Singh 
Phone: 021-4066041; email: Shajila.Singh@uct.ac.za 
2. Mrs Lucretia Petersen 
Phone: 021-4066993; email: Lucretia.Petersen@uct.ac.za 
3. Mrs Christine Rogers 
Phone: 021-4066315; email: Christine.Rogers@uct.ac.za 
Chairperson of the Research Ethics Committee, Prof Marc Blockman 
Phone: 021-4066496 











University of Cape Town 
Division of Communication Sciences and Disorders 
I have read (or had read to me by ____________ ~) fue 
Information Letter. I understand what is required of me (my child/legal ward) and I have had all 
my questions answered. I do not feel tha~ I or my child is being forced to take part in this study 
and we are doing so of our own free will. I know fuat I and my child can wifudraw at any time if 
we so wish and fuat it will have no bad consequences for me or my child. 
Signed: 
Participant Date and place 
Researcher Date and place 












Informed consent form in isiXhosa 
Ifomu enika ulwazi kumzali onomntwana oneminyaka emithathu ngokuzalwa. 
Mzali obekekileyo/mgcini ngokusemthethweni 
Igama lam ndinguN azanin Ghafari ongumnfundi kweze Audiology kwiDyunivesithi yase 
Ntshona Koloni. Ndenza olu phando ngabantwana abathatha okanye abamele ukuba bathatha 
amachiza kwisifo sephepha. Injongo yesi sifundo ndisenzayo lujongisele entweni yokuba 
ndifumane iingcukacha nolwazi oluthe vetshe ngomntwana lowo. Esi sifundo sijongisele kwaye 
sixhaswa leli qela lingezantsi Research Ethics Committee (REC) of the Faculty of Health 
Sciences, University of Cape Town. (REC Reference Number: 010/2010). 
Injongo yesi sifundo 
Umntwana ngelinye ixesha uyakuthi afumane amachiza esifo sephepha, machiza lawo anokuthi 
abakhokhelisele engozini yokungeva. Iinjongo zethu zikhokhelisele entweni yokuba abantwana 
abanesifo sephepha sibancede. Abantwana abafumana amachiza wesifo sephepha bayakwazi 
ukubanengxaki yokuva kade. Kungcono ukuqaphela komntwana kwangoko. Ukuba umntwana 
ubonwe ngathi akeva, uyakuthunyelwa kwangoko ayokuhlolwa kwaye kwangoko uyakuthi 
afumane UIicedo. 
Emva kwelo ncedo umntwana uye abuyele kwisimo bekufaneleke ukuba abekuzo, ngokuthi 
akwazi kakuhle ukuthetha ulwimi lakhe kunye nabanye abantwana. Kuyakwaziswa oogqirha 











Ingaba esi sifundo usithatbayo sithetha ukuthini kuwe? 
Umphandi lowo uyakutbi ajonge umphandle wendlebe yomntwana lowo. Kubalulekile ukujonga 
indlebe yomntwana ngaphakatbi nangaphandle, ukuze uqiniseke ukuba iindlebe zakhe zisebenza 
kakuhle. Umphakatbi wendlebe yomntwana uyakujongwa ukuba usebenza kakuhle na. xa 
kusenziwa olu vavanyo lwendlebe olubizwa nje nge Tympanometry & Acoustic Reflex sube 
kusenzwa uvavanyo. Ukuba kuye kwafunyaniswa ukuba umntwana lowo unengxaki 
nomphakatbi wendlebe yakhe uyakutbi athunyelwe kugqirha, kwisibhedlele ekutbiwa Yl 
Brooklyn Chest Hospital. 
Ukuba umntwana wakho uthe wavavanywa waze wafunyaniswa ukuba unengxaki kumphakatbi 
wendlebe yakhe (Ie nqubo iyafana nqwa nale yenziwa ngoogqirha okanye noomongikazi xa 
befuna ukubona ubushushu bomntwana endlebeni yakhe. Uphando 010 luyakuveza isandi kwaye 
kuyakusetyenziswa imakrofowuni eyakutbi icishilele iziphumo zomphakatbi wendlebe 
yomntwana. Kwelinye icala 10 vavanyo kuyakuboniswa kudityaniswe, umtshini apho uyakutbi 
kusixelele ukuba usebenza kakuhle umphakatbi wendlebe yomntwana wakho. Okanye kufanele 
umntwana athunyelwe kuncedo lwe- audiology. Ngexesha 10 vavanyo kunokwenzeka ukuba 
umntwana alale okanye angalali. Umphandi lowo uyakutbi anze uvavanyo lokujonga ukuba 
umthambo wokuva ukuba uyasebenza na. Ngolu vavanyo i-Automated Auditory Brainstem 
Responses kuyakusetyenziswa isipontshi sokucoca ufele lwentloko yomntwana, isibunzi kunye 
nomphezulu wendlebe. Emva koko kuyakutbi kudyibhelwe amafutha ayakutbi ancede esi ndawo 
zikhankanyiweyo ngentla, nalapho kuyakufakwa khona incam yamacingo ombane. (electrodes). 











komntwana. La macingo ombane athi atsalwe aze adityaniswe kunye nekhomputha, ukuze 
iziphumo zibenako ukucaciswa. 
Ukuba umntwana uye walitshona olu vavanyo lweendlebe kunye nelo mthambo wendlebe, 
uyakuthi athunyelwe kwisibhedle1e i-Red Cross Hospital apho anokuthi afumane khona olunye 
uvavanyo 10kuthomala1isa Auditory Brainstem Responses & Auditory Steady-State Responses. 
Apho nokuthi kubonwe khona ubume bomntwana wakho ukuba uva kangakanani na. Enye 
ingqubo ethe vetshe eyi-Auditory Brainstem Responses & Auditory Steady-State Responses, 
iyakuthi yenziwe e-Red Cross Hospital kubonwe khona ukuba umntwana lowo uyeva na. Ie 
nqubo iyakuthi yenziwe ngumqeshwa wakhona obizwa ukuba yi- audiologists. 
Isizathu soluvavanyo, kuyakuthi kuncamathiselwe izitikaJamaphetshana amane entlokweni 
yomntwana, kwaye iqhakamishelane nekhomputha. Kuyakuthi kufakwe isimameli-ndlebe 
ezindlebeni zomntwana. Kuyakuthi gqi isandi kwindlebe nganye sisiza ngesimameli ndlebe, 
ngalumzuzu ikhomputha ishicilela iziphumo. 
Umntwana wakho kufuneka elele ngexesha 10 vavanyo. Ukuba umntwaba wakho ungaphantsi 
kwenyanga ezintandathu, akanako ukunyangwa elele. Kwaye Ie nqubo isenza xa elele, xa 
egqibile ukutya. Ukuba umntwana ungaphezu kweenyanga ezintandathu, uyakuthi ahlolwe 
ngugqirha ukuba uphilile kakuhle na ukuba angawafumana na amachiza, ukuze akwazi ukulala 
ngexesha 10 vavanyo. Ukuba umntwana uphilile kakuhle, ugqirha uyakuthi amnike amachiza 
(amayeza). Isizakuthu sokuba umntwana kufanele alale ngexesha 10 vavanyo kwenzelwa ukuba 
athomalaIe, akhululeke ngexesha 10 vavanyo. Kwaye lonto inzima kwabantwana abancinci. 
Umqashwa wasesibhedlele uyakuthi achophele 010 vavanyo kumntwana lowo, ngexa umntwana 











abanomdla wokulenza olu vavanyo. Umongikazi uyakutbi ahlala eli liso kwel0 vavanyo, uyatbi 
aqisekise ukuthi umntwana uvukile ngaphambi kokuba aphume esibhedlele. Abaphandi 
bayakuthi bafumane imvume xa uvavanyo lugqityiwe. Emva kolu vavanyo lwenziwayo uyakutbi 
umntwana ahlaliswe phantsi aphumle, siyakuthi silenze olu vavanyo xa ethe umntwana wakho 
wakuvuma oko. 01u vavanyo liyakuthatha ixesha elingange mizuzu emashumi amathathu ukuya 
kwimizuzu emashumi amane. Kuyakuxhomekeka kuvavanyo oluyakwenziwa emtwaneni 10wo. 
Abantwana abayakutbi bathunyelwe eRed Cross Hospital bayakuthunyelwa kuphando 10 
kuthomalalisa, 010 vavanyo luyakuthatha iyure ezimbini. 
Ubungozi nobunzima 
01u vavanyo lwenziwa qho ukujonga abantwana. 
Lonke uvavanyo alunazo iintlungu emntwaneni. 
Abantwana abathi bathunyelwe eRed Cross Hospital beyokuxilongwa malunga novavanyo lwe-
additional audiometric, ukunyangwa ngeezizolisi (iipilisilamayeza), Zikwakhona nezizolisi 
ezinobungozi kodwa ezi aziqhelekanga kwaphela. 
Ngamanye amaxesha amachiza enza ukuba umntwana angonwabi, angaphumli phambi kokuba 
alale. 
Umzekelo: Kubantwana abatyebileyo abanengxaki nobuphaku-phaku kuye kubekho 
ubungozilingxaki, kuba 10 machiza abangela ukuba umntu alale kwikhoma okanye abhubhe. 











Ngumba onqabileyo lona apha ekapa, kuba awuzange wenzeka kangangethuba elingamashumi 
amabini apha ekapa. 
Ugqirha okanye umongikazi owufundeleyo 10 msebenzi ufanele ukuba ajongane nayo yonke into 
eqhubekayo, ajonge uvavanyo namachiza ukuba akhutshwa ngendlele esibhed1ele. Zonke 
izixhobo ezisetyenziswayo kunyanzelekile ukuba zifumaneke, ukenzela ukunceda umntwana 
wakho. 
Uzakuthi waziswe olunye usuku omawuyokuvela ngalo esibhedlele, siyakukhuthaza kangangoko 
ukuba ubesecaleni komntwana wakho. Siyakucela ukuba ungothuki okanye ubenedyudyu. 
Nangona olu vavanyo luxhalabisa kodwa kufanele ukuba lwenziwe qho kwesi sibhed1ele okanye 
jikelele, ukuze kuvavanywe abantwana abancinci kakhulu. 
Inzuzo: 
Ukuba umntwana wakho uthe wanengxaki yokuva siyakwazi ukuthumela kugqirha amaqaphele 
kwangethuba. Simthumele enziwe olunye uvavanyo lwendlebe, lwempumlo, nomqala Ukuba 
ugqiba uthe ngexesha 10 vavanyo wanezinto aziqaphelayo ezingahambi ngendlela uyakwazi 
ukumtshintsha kwezo pilisilamayeza ebewasebenzisa. Amkhusele kwamanye amachiza anokuthi 
amnike ingxaki. 
Umntwana wakho uyakuthi afumana amaphetshane okanye ipeni kuba ethe wathatha inxaxheba 
kwesi sifundo. Iziphumo zolu phando zinalo ugalelo ebantwaneni, kubantwana abanesifo 











Ukuzinikela okanye uzigqatse: 
Kwesi sifundo uyakwazi ukuzinikela ngokuzigqatsa. Ukuba ufuna umntwana wakho 
angasingeneli kulungile kodwa yena uyakuhlala eqhubekeka ngokuphathwa ngesihoyo 
ngaphandle kwesohlwayo. Uvumelekile umntwana wakho kuba alungene olu hlobo, kwaye 
nokuba aphinde aluyeke nanini na usavumelekile. Ndikucebisa ukuba umvumele umntwana 
ukuba angene koluh1010. Ukuba uyathanda ungamsa umntwana ayokuhlolwa ukuba uva 
kangakanani na, kwisibhedlele iBrooklyn Chest Hospital. Ukuba ude wagqiba ukuba umntwana 
wakho makaye kolu hlolo lokuva, sithanda ukucebisa ukuba uqaphele ukuba umntwana lowo 
uyeva kakuhle, ngakumbi xa ethe wamamelisisa kulento ayenziwayo. Kubalulekile emntwaneni 
wakho into yokuba eve okanye amamelisise xa abantu bethetha naye, ukuze azokwazi ukufunda 
ukuthetha nabanye abantu. Ukuba ungumntu okhathalayo malunga nokuva komntwana wakho 
ndiyakuthanda ukuba uye nokuba kunini nomntwana eRed Cross Children's hospital okanye 
eTygerberg Hospital, ayokuhlolwa ukuba uva kangakanani na. 
lkusemfihlweni: 
Yonke ingcukacha efunyanwe ngomntwana wakho ngoku ese Brooklyn Chest Hospital nasemva 
kokuba ekhululwe khona iyakugcinwa ihlale isemfihlweni kuthi. Amacwecwe okanye oko 
kubhaliweyo ngomntwana wakho ziyakuhlala kwizandla ezithembekileyo kwaye elugcinweni. 
Asisoze sibonise nowuphi na umntu, ngaphandle kwabantu abaphethe 10 mcimbi wohlonyo 
okanye abezempilo, kwaye abasebenza ngalo mntwana. Wena nomntwana wakho nikhuselekile 











Ukuba ufuna iincukacha ezithe vetshe okanye kukho into ofuna ukuyiqonda, qhakamishelana 
nam okanye okanye omnye wabaphathi bam. Igama lam ndingu Nazanin Ghafari, iminxeba 
onokundifumana kuyo yile ilandelayo 0788335350· and my email address is 
nazanin _gh59@yahoo.com. 
Abaphathi bam ngoo: 
1. Prof Shajila Singh 
Phone: 021-4066041; email: Shajila.Singh@uct.ac.za 
2. Mrs Lucretia Petersen 
Phone: 021-4066993; email: Lucretia.Petersen@uct.ac.za 
3. Mrs Christine Rogers 
Phone: 021-4066315; email: Christine.Rogers@uct.ac.za 
Ochophele 10 mcimbi we- Research Ethics Committee, ngu Prof Marc Blockman 
Umnxeba: 021-4066496 











Ifomu enika ulwazi kumzali onomntwana oneminyaka emithathu ngokuzalwa 
Mzali obekekileyo/mgcini ngokusemthethweni 
Igama lam ndinguNazanin Ghafari ongumnfundi kweze Audiology kwiDyunivesithi yase 
Ntshona Koloni. Ndenza olu phando ngabantwana abathatha okanye abamele ukuba bathatha 
amachiza kwisifo sephepha. Injongo yesi sifundo ndisenzayo lujongisele entweni yokuba 
ndifumane iingcukacha nolwazi oluthe vetshe ngomntwana lowo. Esi sifundo sijongisele kwaye 
sixhaswa leli qela lingezantsi Research Ethics Committee (REC) of the Faculty of Health 
Sciences, University of Cape Town. (REC Reference Number: 010/2010). 
Injongo yesi sifundo 
Umntwana ngelinye ixesha uyakuthi afumane amachiza esifo sephepha, machiza lawo anokuthi 
abakhokhelisele engozini yokungeva. Iinjongo zethu zikhokhelisele entweni yokuba abantwana 
abanesifo sephepha sibancede. Abantwana abafumana amachiza wesifo sephepha bayakwazi 
ukubanengxaki yokuva kade. Kungcono ukuqaphela komntwana kwangoko. Ukuba umntwana 
ubonwe ngathi akeva, uyakuthunyelwa kwangoko ayokuhlolwa kwaye kwangoko uyakuthi 
afumane uncedo. 
Emva kwelo ncedo umntwana uye abuyele kwisimo bekufaneleke ukuba abekuzo, ngokuthi 
akwazi kakuhle ukuthetha ulwimi lakhe kunye nabanye abantwana. Kuyakwaziswa oogqirha 
ukuze bakwazi ukumnika amachiza, machiza lawo ayakuthi amncede. 











Umphandi lowo uyakuthi ajonge umphandle wendlebe yomntwana lowo. Kubalulekile ukujonga 
indlebe yomntwana ngaphakathi nangaphandle, ukuze uqiniseke ukuba iindlebe zakhe zisebenza 
kakuhle. Umphakathi wendlebe yomntwana uyakujongwa ukuba usebenza kakuhle na. xa 
kusenziwa olu vavanyo lwendlebe olubizwa nje nge Tympanometry & Acoustic Reflexsube 
kusenzwa uvavanyo. Ukuba kuye kwafunyaniswa ukuba umntwana lowo unengxaki 
nomphakathi wendlebe yakhe uyakuthi athunyelwe kugqirha, kwisibhedlele ekuthiwa yi 
Brooklyn Chest Hospital. 
Umphakathi wendlebe womntwana wakho uxakuxilongwa ukwenzela kuzobonwa ukuba yonke 
into iyasebenza, umntwana lowo uzakucelwa ukuba atsho xa esiva izandi. 
Ukuba umntwana wakho uthe wanengxaki nendlebe uzokuthunyelwa kuchwephetshe wendlebe 
ukuze ayohlolwa ngokuphangaleleyo. 
N galemivavanyo umntwana wakho uzokwazi ukuhlala ngokungakhathazeki, sizokwenza 
amavavanyo ngokufuna komntwana wakho. Lamavavanyo azothatha malunga nemizuzu eyi 30 
uyokumba kwi 45 kuxhomekeke ekuveni komntwana lowo. 
Ubungozi nobunzima 
• Lamavavanyo asetyenziswa maxa onke ukujonga ukungeva komntwana. 













Ukuba umntwana wakho uthe wanengxaki yokuva siyakwazi ukuthumela kugqirha amaqaphele 
kwangethuba. Simthumele enziwe olunye uvavanyo lwendlebe, .lwempumlo, nomqala. Ukuba 
ugqiba uthe ngexesha 10 vavanyo wanezinto aziqaphelayo ezingahambi ngendlela uyakwazi 
ukumtshintsha kwezo pilisi/amayeza ebewasebenzisa. Amkhusele kwamanye amachiza anokuthi 
amnike ingxaki. 
Umntwana wakho uyakuthi afumana amaphetshane okanye ipeni kuba ethe wathatha inxaxheba 
kwesi sifundo. lziphumo zolu phando zinalo ugalelo ebantwaneni, kubantwana abanesifo 
sephepha. Abafumana amachiza anokuthi amkhokhelela ekungaviyo kakuhle. 
Ukuzinikela okanye uzigqatse: 
Kwesi sifundo uyakwazi ukuzinikela ngokuzigqatsa. Ukuba ufuna umntwana wakho 
angasingeneli kulungile kodwa yena uyakuhlala eqhubekeka ngokuphathwa ngesihoyo 
ngaphandle kwesohlwayo. Uvumelekile umntwana wakho kuba alungene olu hlobo, kwaye 
nokuba aphinde aluyeke nanini na usavumelekile. Ndikucebisa ukuba umvumele umntwana 
ukuba angene koluhlolo. Ukuba uyathanda ungamsa umntwana ayokuhlolwa ukuba uva 
kangakanani na, kwisibhedlele iBrooklyn Chest Hospital. Ukuba ude wagqiba ukuba umntwana 
wakho makaye kolu hlolo lokuva, sithanda ukucebisa ukuba uqaphele ukuba umntwana lowo 
uyeva kakuhle, ngakumbi xa ethe wamamelisisa kulento ayenziwayo. Kubalulekile emntwaneni 
wakho into yokuba eve okanye amamelisise xa abantu bethetha naye, ukuze azokwazi ukufunda 
ukuthetha nabanye abantu. Ukuba ungumntu okhathalayo malunga nokuva komntwana wakho 
ndiyakuthanda ukuba uye nokuba kunini nomntwana eRed Cross Children's hospital okanye 












Yonke ingcukacha efunyanwe ngomntwana wakho ngoku ese Brooklyn Chest Hospital nasemva 
kokuba ekhululwe khona iyakugcinwa ihlale isemfihlweni kuthi. Amacwecwe okanye oko 
kubhaliweyo ngomntwana wakho ziyakuhlala kwizandla ezithembekileyo kwaye elugcinweni. 
Asisoze sibonise nowuphi na umntu, ngaphandle kwabantu abaphethe 10 mcimbi wohlonyo 
okanye abezempilo, kwaye abasebenza ngalo mntwana. Wena nomntwana wakho nikhuselekile 
kakhulu , anisoze nipapashwe nakancinci kwesi sifundo senziwayo. 
Ukuba ufuna iincukacha ezithe vetshe okanye kukho into ofuna ukuyiqonda, qhakamishelana 
nam okanye okanye omnye wabaphathi bam. Igama lam ndingu Nazanin Ghafari, iminxeba 
onokundifumana kuyo yile ilandelayo 0788335350 and my email address is 
nazanin gh59@yahoo.com. 
Abaphathi bam ngoo: 
1. Prof Shajila Singh 
Phone: 021-4066041; email: Shajila.Singh@uct.ac.za 
2. Mrs Lucretia Petersen 
Phone: 021-4066993; email: Lucretia.Petersen@uct.ac.za 
3. Mrs Christine Rogers 
Phone: 021-4066315; email: Christine.Rogers@uct.ac.za 
Ochophele 10 mcimbi we- Research Ethics Committee, ngu Prof Marc Blockman 
Umnxeba: 021-4066496 











University of Cape Town 
Division of Communication Sciences and Disorders 
Mna. _______ othe wafunda Ie ngcazelo ikule leta _______ _ Ndiyayazi 
kwaye ndicacelwa okanye indinika ingcazelo ngokuthe vetshe, kwaye nemibuzo yarn. 
iphenduiekile. Andiziva ngathi umntwana warn. uye wanyanzelwa ukuba azingenele ezi zifundo. 
Ndiyayazi ukuba ezi zifundo zizakuba yinzuzo kum. nakuye. 
Isandla esityikityileyo: 
Umthathi nxaxheba Umhla kunye nendawo 
Umphandi Umhla kunye nedawo 












Informed eonsent form in Afrikaans 
ingelig toestemming vorm vir ouers van deelnemers onder die ouderdom van 3 jaar 
Liewe 1 ouer/voog 
Ek is Nazanin Ghafari, nagraadse dame student in audiologie aan die Universiteit van Kaapstad. 
Ek doen tans navorsing betreffende die geboor van kinders wat medikasie vir Tuberkulose (TB) 
ontvang. Die doel van hierdie studie vereis egter dat ek toegang tot jou kind se mediese rekords 
verkry, o.a. sy/haar mediese geskiedenis en ander toepaslike informasie. Hierdie studie bet reeds 
etiese goedkeuring ontvang van die Navorsing Etiese Kommitee (ree) van die fakulteit 
Gesondheidswetenskappe, Universiteit van Kaapstad (ree Verwysingsnommer: 010/2010). 
Doell vanl dielstudie: 
Kinders ontvang soms Tb medikasie wat bulle egter blootstel tot die risiko om In geboorverlies te 
ontwikkel. Die doel van hierdie studie is om kinders wat Tb bet en Tb medikasie ontvang, wat 
weI geboorprobleme ondervind, te identifiseer. Vroeer identiftkasie van slilke gevalle van 
geboorverlies sal ook dus beter vir die kind wees. Indien die kind weI In geboorverlies onderlede 
is, kan by/sy verwys word vir verdere ondersoek/bebandeling (van bul geboor) en uiteindelik ook 
vroeer bebandeling kry. Die kind sal dus die beste kans be te ontwikkeling van sy/haar taal en 
kommunikasie vaardighede. In aanvu1ling, vroeer identifikasie dien terselftertyd as waarskuwing 
vir dokters, sodat bulle selfs altematiewe medikasie kan oorweeg vir jou kind, wat moontlik nie 












Die navorser sal eerstens die buite-oor van jou kind ondersoek. Dit is belangrik om binne die 
kind se oor te kyk, ten einde seker te maak dat daar niks in die oor is en dat sy/haar oordrom 
normaal is. Daarna sal jou kind se middel-oor getoets word om te ondersoek hoe goed "dit 
funksioneer. Gedurende hierdie toets (tympanometrie & Akoestiese reflekse) sal In probe in jou 
kind se ore geplaas word. Indienjou kind weI In middel-oor probleem het, sal hy/sy verwys word 
na In dokter by Brooklyn Chest Hospitaal. 
Die binne-oor van jou kind sal getoets word deurdat In peilstif gepas met In sagte punt in die oor 
kanaal geplaas word (hierdie prosedure is soortgelyk aan die ondersoek waartydens 
dokterslverpleegsters jou kind se temperatuur vanaf die oor neem). Die wyse waarop hierdie 
ondersoek geskied behels In klank geproduseer deur die probe en wat In mikrofoon bevat, wat die 
reaksie van die binne-oor opneem en registreer. Die ander deel van die probe is gekoppel aan die 
screening machine, wat uiteindelik sal bepaal of jou kind se binne-oor weI normaal is en indien 
ons sy/haar moet verwys na audiologie dienste. Jou kind mag slaapend of wakker wees 
gedurende hierdie ondersoek. Die navorser sal daama die funksionering van jou kind se 
gehoorsenuwee toets. Vir hierdie toets (Automatiese hoorbaar brainstem antwoorde), sal ek 
gebruik maak van In cotton swab om die vel van jou kind se kop, voorhoof en een oorskulp 
skoon te maak. Daama sal paste geplaas word op die vel in die skoon areas soos voorheen 
genoem, waarvolgens elektrodes aangeheg sal word. In Elektrode bevat In klein disket aan een 
end, wat funksioneer deur seinimplulse geproduseer deur jou kind se gehoorsenuwee sal 
identifiseer op grond van I reaskie op In spesifieke "kliek" klank. Die elektrodes is gekoppel aan 











Indien jou kind Die die binne-oor, en gehoor senuwee toetse slaag Die, sal hy/sy na Rooi Kruis 
Hospitaal verwys word vir verderdiagnostiese toetse (hoorbaar brainstem antwoorde & hoorbaar 
gereelde-toestand antwoorde) om te bepaal tot watter vlak jou kind kan hoor. Hierdie prosedure 
sal uitgevoer word by die Rooi Kruis Hospitaal deur die audioloog wat daar diensagtig. Vir die 
doel van hierdie toets sal vier klein plakkers geplaas word op jou kind se hoof, wat verder 
gekoppel is aan die rekenaar. Oorfone sal oor jou kind se ore geplaas. In die proses sal klanke 
gestuur word deur die oorfone tot elke oor apart, terwyl die rekenaar die uitslae lees en registreer. 
Jou kind behoort te slaap vir die duur van hierdie toets. Indien jou kind egter onder die ouderdom 
van ses maande is, sal hy/sy Die sedated, en die toets sal uitgevoer word terwyl hy/sy normaal 
slaap, nadat sy/hy gevoed is. Indien jou kind egter oor die ouderdom van ses maande is, sal hy/sy 
behandel word deur In physician/verpleegster by die Rooi Kruis Hospitaal. Hierdie is In roetine 
proses wat in verbruik kom in die geval van klein kinders wat sodanige gehoor toetse benodig. 
Hierdie toets is Die pynlik of ongemaklik in enige hoedanigheid Die, maar daar word egter 
verwag dat jou kind slaapend wees ten einde skoon en akkurate opnames gedurende die toets te 
verkry. Die navorser sal daarvolgens toegang verkry tot die uitslae, sodra die toetse uitgevoer is. 
Vir hierdie toetse sal jou kind gemaklikke sitplek verleen en rus verskaf word, en sal die toetse 
alleen1ik uitgevoer word sodra jou kind ingestem tot die toetse. Die toetse sal ongeveer 30 tot 40 
minute duur, afhangend van gehoorstatus van die betrokke kind. Vir kinders verwys na Rooi 
Kruis Hospitaal vir verder diagnostiese toetse, sal dit ongeveer 2 ure duur. 
Risikol enl Ongerief: 
• Hierdie toetse word roetinelik gebruik in gehoorondersoeke van kinders. 











• Kinders verwys na Rooi Kruis Hospitaal vir addisionele audiometriese ondersoeke onder 
sedation; daar is sommige newe-effekte wat die medikasie mag teweegbring, maar hierdie is 
egter in baie seIde gevaUe. Die medikasie mag egter jou kind rusteloos maak voor hulle aan die 
slaap val. Kinders wat aan vetsug lei, o.a. baie vet, of wie probleme hul senuweestelsel 
ondervind, sal daar In effense verhoogde risiko wees dat die medikasie tot In koma of selfs die 
dood kan lei. Ons wens dat u dus sal kennis dra van hierdie informasie en wat beteken. Hierdie is 
egter In baie seldsame geval en het nie voorgekom in die Kaapstad area gedurende die afgelope 
20 jare. In Mediese professioneel (dokter of verpleegster) is op roetine basis verantwoordelik om 
beheer te handhaaf oor die medikasie en die toetse word by In hospitaal gedoen, wat oor al die 
nodige middele en huipmateriale beskik, om jou kind te help indien dit weI sou benodig word. U 
sal in kennis gestel word van die datum en tyd van die afspraak en waarby ons u aanmoedig om, 
indien moontlik, by u kind te wees. Moet dus asseblief nie verskrik wees nie. Alhoewel dit baie 
kommerwekkend mag klink, kan ons u aanse dat dit In roetine toets is wat gereeld gedoen word 
by hierdie hospitaal en rondom die wereld, waarby die gehoor van baie klein kinders getoets 
word. 
Voordele: 
Indien jou kind weI In gehoorverlies het, kan ons dit op In vroee stadium identifiseer en homlhaar 
verwys vir verdere toetse of ondersoek deur In oor-, neus- en keel-dokter. Indien die betrokke 
dokter onseker of waaksaamagtig is betreffende die effek van medikasie op jou kind se gehoor, 
mag hy/sy die medikasie verander en dus op. hierdie manier jou kind beskerm teen verder 
medikasie-verwante gehoor verlies. Jou kind sal plakkers of In pen ontvang vir sy/haar deelname 
aan die studie. Die uitslae van die studie mag ook verder bydra tot 'n reeks van dienste wat 













Deelname aan hierdie studie is vrywillig. Indien u besluit dat jy jou kind nie wi1laat deelneem 
aan hierdie studie nie, sal jou kind steeds standaard sorg ontvang sonder enige oordeel of 
boetes. Indien u instem dat jou kind weI mag deelneem, maar later egter besluit om die 
gehoortoetse te staak, is u welkom om eruge tyd so te do en. 
Ek wi! u aanmoedig om u kind se gehoor te laat toets sodat hy/sy die nodige behandeling en 
sorg kan ontvang. Indien u so verkies kan die routine audioloog by die Brooklyn Chest 
Hospitaal jou kind se gehoor toets. Indien u daarteen besluit om jou kind se gehoor te laat toets, 
wi! ons u graag aanraai on aandag te verleen op grond van hoe u kins reageer op klanke rondom 
homlhaar, veral of hy/sy aandag gee wanneer u met homlhaar praat. Dit is belangrik vir u kind 
om te luister hoe mense gesels, sodat hy/sy kan voortdurend kommunikasie vaardighede sal 
aanleer. Indien u begin bekommerd raak rakende jou kind se gehoor in die toekoms, gaan 
asseblief na Rooi Kruis kindershospitaal of Tygerberg hospitaal vir gehoortoetse. 
Vertroulikheid: 
Aile informasie ingesamel gedurende jou kind se verblyf by die Brooklyn Chest hospitaal en 
selfs nadat hul ontslaan is, sal met alle vertroulikheid hanteer word. Jou kind se hospitaalrekords 
en die uitslae van die toetse sal versigtig hanteer word, en sal nie aan enigeen getoon word 
behalwe die gesondheids professioneel lede wie met jou kind gewerk het. U en u kind sal nie 
identifiseerbaar wees in enige publikasies van hierdie studie nie. 











Nazanin Ghafari, kontak nommer is 0788335350, en e-pos adres is nazanin~59@yahoo. com 
1. Prof. Shajila Singh 
Foon: 021-4066041; E-pos: shajila. singh@Uct. ac. za 
2. Lucretia Petersen 
Foon: 021-4066993; E-pos: lucretia. petersen@Uct. ac. za 
3. Mev. Christine Rogers 
Foon: 021-4066315; E-pos: christine. rogers@uct. ac. za 
Chairperson van die navorsing etiek kommitee, Prof. Marc Blockman 
Foon:021-4066496 











Ingelig toestemmingvorm vir ouers van deelnemers bo die ouderdom van 3 jaar 
Doellvanldielstudie: 
Ek is Nazanin Ghafari, nagraadse damestudent in audiologie aan die Universiteit van Kaapstad. 
Ek doen tans navorsing betreffende die gehoor van kinders wat medikasie vir Tuberkulose (TB) 
ontvang. Die doel van hierdie studie vereis egter dat ek toegang tot jou kind se mediese rekords 
verkry, o.a. sy/haar mediese geskiedenis en ander toepaslike infonnasie. Hierdie studie het reeds 
etiese goedkeuring ontvang van die Navorsing Etiese Kommitee (ree) van die fakulteit 
Gesondheidswetenskappe, Universiteit van Kaapstad (ree Verwysingsnommer: 010/2010). 
Doellvanldielstudie: 
Kinders ontvang soms Tb medikasie wat hulle egter blootstel tot die risiko om In gehoorverlies te 
ontwikkel. Die doel van hierdie studie is om kinders wat Tb het en Tb medikasie ontvang, wat 
weI gehoorprobleme ondervind, te identifiseer. Vroeer identifikasie van sulke gevalle van 
gehoorverlies sal ook dus beter vir die kind wees. Indien die kind weI In gehoorverlies onderlede 
is, kan hy/sy verwys word vir verdere ondersoeklbehandeling (van hul gehoor) en uiteindelik ook 
vroeer behandeling kry. Die kind sal dus die beste kans he te ontwikkeling van sy/haar taal en 
kommunikasie vaardighede. In aanvulling, vroeer identifIkasie dien terselftertyd as waarskuwing 
vir dokters, sodat hulle selfs altematiewe medikasie kan oorweeg vir jou kind, wat moontlik nie 
In nadelige uitwerking het op jou kind se gehoor nie. 
Watlbetekenldeelnamelaanlhierdielstudie? 
Die navorser sal eerstens die buite-oor van jou kind ondersoek. Dit is belangrik om binne die 











nonnaal is. Daarna sal jou kind se middel-oor getoets word om te ondersoek hoe goed dit 
funksioneer. Gedurende hierdie toets (tympanometrie & Akoestiese reflekse) sal In probe in jou 
kind se ore geplaas word. Indienjou kind weI In middel-oor probleem het, sal hy/sy verwys word 
na In dokter by Brooklyn Chest Hospitaal. 
Jou kind se binneste oor en hoorbaar senuwee funksie sal wees geskat deur te plaas hooffone op 
jou kind se ore. shelhe sal gevra word om te dui aan wanneer shelhe hoor die klanke. 
Indien jou kind het In binneste oor of hoorbaar senuwee probleem, he/she sal verwys word na 
audiology dienste vir verder diagnosering assessments. 
Vir hierdie toetse, jou kind sal wees gesetel gemaklik; ons sal aIleen dra uit die toets sodra jou 
kind het saamgestem tot die toetse. die toetse sal neem ongeveer 30 to 45 minute athangend op 
verhoor status van die kind. 
Risikol enl Ongerief: 
• These toetse IS gebruik roetinelik In verhoor assessments van kinders. 
• There is geen risikos vir jou kind, almal toetse is nie-invallende en is nie pynlik totjou kind. 
VrywilliglDeelname: 
Deelname aan hierdie studie is vrywillig. Indien u besluit dat jy jou kind nie wil laat deelneem 
aan hierdie studie nie, saljou kind steeds standaard sorg ontvang sonder enige oordeel ofboetes. 
Indien u instem dat jou kind weI mag deelneem, maar later egter besluit om die gehoortoetse te 











Ek wil u aanmoedig om u kind se gehoor te laat toets sodat hy/sy die nodige behandeling en sorg 
kan ontvang. Indien u so verkies kan die routine audioloog by die Brooklyn Chest Hospitaal jou 
kind se gehoor toets. Indien u daarteen besluit om jou kind se gehoor te laat toets, wil ons u 
graag aanraai on aandag te verleen op grond van hoe u kins reageer op klanke rondom hom/haar, 
veral of hy/sy aandag gee wanneer u met hom/haar praat. Dit is belangrik vir u kind om te luister 
hoe mense gesels, sodat hy/sy kan voortdurend kommunikasie vaardighede sal aanleer. Indien u 
begin bekommerd raak rakende jou kind se gehoor in die toekoms, gaan asseblief na Rooi Kruis 
kindershospitaal of Tygerberg hospitaal vir gehoortoetse. 
Vertroulikheid: 
AIle informasie ingesamel gedurende jou kind se verblyf by die Brooklyn Chest hospitaal en 
selfs nadat hul ontslaan is, sal met alle vertroulikheid hanteer word. Jou kind se hospitaalrekords 
en die uitslae van die toetse sal versigtig hanteer word, en sal nie aan enigeen getoon word 
behalwe die gesondheids professioneel lede wie met jou kind gewerk het. U en u kind sal nie 
identifiseerbaar wees m enige publikasies van hierdie studie me. 
Vir enige verdere navrae voel asseblief vry om my te kontak en my promotor, my naam is 
Nazanin Ghafari, kontak nommer is 0788335350, en e-pos adres is nazanin_gh59@yahoo. com. 
I.Prof. Shajila Singh 
Foon: 021-4066041; E-pos: shajila. singh@uct. ac. za 
2. Lucretia Petersen 
Foon: 021-4066993; E-pos: lucretia. petersen@Uct. ac. za 











Foon: 021-4066315; E-pos: Christine. rogers@uct. ac. za 
Chairperson van die navorsing etiek kommitee, Prof. Marc Blockman 
Foon:021-4066496 











Universiteit van Kaapstad 
Divisie Kommunikasie wetenskappe en wanordes 
Ek het informasie brief gelees (of is deur aan my 
voortgelees). Ek verstaan wat van my vereis word (my kind/wettige ward) en dat al my vrae 
beantwoord is. Ek voel nie dat ek of my kind geforseer is om deel te neem aan hierdie studie nie 
en sodoende doen ons dit uit vrye wi!. Ek weet dat ek en my kind enige tyd kan ontrek indien ons 
sou wou en dat geen sleg gevolge sal dra vir my of my kind nie. 
Geteken: 
Deelnemer Plek en Datum 
Navorser Plek en Datum 
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Audiologic Tests Results 
Middle ear status Hearing status 
No Age Ear (pre medical intervention} (post medical intervention} 
group Otoscopy Tymp IpsiAR Audiometry OAE 
Outer TM (Type) Type Degree Shape + 
Ear AABR 
III R NAD NAD A Present SNHL Slight Flat 
L NAD NAD A Present SNHL Slight Flat 
2 III R NAD NAD A Absent SNHL Nonnal HFL 
L NAD NAD A Absent SNHL Nonnal HFL 
3 III R NAD NAD A Absent Pass 
L NAD NAD A Present Pass 
4 II R NAD NAD A Present NH Nonnal 
L NAD NAD A Present NH Nonnal 
5 R NAD NAD e Absent Discharged 
L NAD NAD B Absent Discharged 
6 III R NAD NAD e Absent MixedHL Slight HFL 
L NAD NAD A Absent MixedHL Nonnal HFL 
7 R NAD NAD e Absent Pass 
L NAD NAD B Absent Pass 
8 III R NAD NAD A Present NH Nonnal 
L NAD NAD A Present SNHL Nonnal HFL 
9 R NAD Bulging & red A Present Pass 
L NAD Bulging & red A Present Pass 
10 III R NAD NAD A Present NH Nonnal 
L NAD NAD A Present SNHL Nonnal HFL 
II II R NAD NAD A Present NH Nonnal 
L NAD NAD B Absent NH Nonnal 
12 III R NAD NAD A Present NH Nonnal 
L NAD NAD A Present NH Nonnal 
13 R NAD NAD A Present Pass 
L NAD NAD A Present Pass 
14 II R NAD NAD A Present NH Nonnal 
L NAD NAD A Present NH Nonnal 
15 III R NAD NAD A Absent MixedHL Slight Flat 
L NAD Perforated CNT eNT MixedHL Profound Flat 
16 R NAD NAD B Absent Pass 
L NAD NAD B Absent Pass 
17 II R NAD NAD A Present SNHL Nonnal HFL 
L NAD NAD A Present NH Nonnal 
18 III R NAD NAD A Present NH Nonnal 
L NAD NAD A Present SNHL Nonnal HFL 
19 R Wax NAD A Present Pass 
L Wax NAD B Absent Pass 1, I:' 
20 II R NAD NAD A Present SNHL Slight HFL 
i L Wax NAD A Present NH Nonnal 21 III R NAD Grommet CNT CNT NH Nonnal 
L NAD NAD B Absent NH Nonnal 
22 III R NAD Perforated CNT CNT Discharged 
L Wax NAD B Absent Discharged 
23 III R Wax NAD B Absent MixedHL Profound Flat 
L NAD NAD A Present MixedHL Severe Flat 
24 R NAD NAD A Present Pass 
L NAD NAD A Present Pass 
25 III R Wax NAD A Present SNHL Nonnal HFL 















R NAD Grommet CNT eNT 
L NAD Grommet CNT eNT 
R NAD Perforated & D CNT eNT 
L NAD NAD A Present 
R NAD NAD A Present 





R NAD NAD B Absent Died 






Note. Hearing test results could not be ascertained for the empty cells. SNHL= sensorineural hearing loss, 
NH= normal hearing, CNT= could not test, NAD= no abnormality detected, R= right, L= left, TM= 
tympanic membrane, AR= acoustic reflexes; D=discharge Participant No 3 was cognitively impaired. 
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